0001493152-22-013812.txt : 20220516 0001493152-22-013812.hdr.sgml : 20220516 20220516161707 ACCESSION NUMBER: 0001493152-22-013812 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QHSLab, Inc. CENTRAL INDEX KEY: 0000856984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112655906 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-19041 FILM NUMBER: 22929295 BUSINESS ADDRESS: STREET 1: 901 NORTHPOINT PARKWAY STREET 2: SUITE 302 CITY: WEST PALM BEACH STATE: FL ZIP: 33407 BUSINESS PHONE: (929) 379-6503 MAIL ADDRESS: STREET 1: 901 NORTHPOINT PARKWAY STREET 2: SUITE 302 CITY: WEST PALM BEACH STATE: FL ZIP: 33407 FORMER COMPANY: FORMER CONFORMED NAME: USA EQUITIES CORP. DATE OF NAME CHANGE: 20151119 FORMER COMPANY: FORMER CONFORMED NAME: USA EQUITY CORP. DATE OF NAME CHANGE: 20151116 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN BIOGENETIC SCIENCES INC DATE OF NAME CHANGE: 19940426 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the period from ______________ to_______________

Commission file number 000-19041

QHSLab, Inc.

(f/k/a USA Equities Corp)

(Exact Name Of Registrant As Specified In Its Charter)

Nevada

30-1104301

(State of

Incorporation)

(I.R.S. Employer

Identification No.)

901 Northpoint Parkway, Suite 302, West Palm

Beach, FL

33407

(Address of Principal Executive Offices)

(ZIP Code)

Registrant’s Telephone Number, Including Area Code: (929) 379-6503

Securities Registered Pursuant to Section 12(g) of The Act:

Title of Each Class		Trading Symbol(s)		Name of each Exchange on Which Registered
Common Stock, $0.0001 Par Value		USAQ		NA

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐

Accelerated filer ☐

Non-Accelerated filer ☐

Smaller reporting company ☒

Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

On May 13, 2022, the Registrant had 8,815,508 shares of common stock outstanding.

TABLE OF CONTENTS

Item	Description	Page

	PART I - FINANCIAL INFORMATION

ITEM 1.	FINANCIAL STATEMENTS.	3
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	17
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	20
ITEM 4.	CONTROLS AND PROCEDURES.	20

	PART II - OTHER INFORMATION

ITEM 1.	LEGAL PROCEEDINGS.	21
ITEM 1A.	RISK FACTORS.	21
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.	21
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES.	21
ITEM 4.	MINE SAFETY DISCLOSURES.	21
ITEM 5.	OTHER INFORMATION.	21
ITEM 6.	EXHIBITS.	21

Cautionary Note Regarding Forward-Looking Statements

This report contains forward-looking statements. Certain of the matters discussed herein concerning, among other items, our operations, cash flows, financial position and economic performance including, in particular, future sales, product demand, competition and the effect of economic conditions, include forward-looking statements.

Forward-looking statements are predictive in nature and do not relate strictly to historical or current facts and generally include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates” and similar expressions. Although we believe that the forward-looking statements contained in this report are based upon reasonable assumptions, these statements and other projections contained herein expressing opinions about future outcomes and non-historical information, are subject to uncertainties and, therefore, there is no assurance that the outcomes expressed in these statements will be achieved.

Investors are cautioned that forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from the expectations expressed in forward-looking statements contained herein. Given these uncertainties, you should not place any reliance on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You are advised, however, to consult any additional disclosures we make in our reports filed with the Securities and Exchange Commission (“SEC”).

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (unaudited)

Condensed Consolidated Balance Sheets – March 31, 2022 and December 31, 2021	4
Condensed Consolidated Statements of Operations – Three Months Ended March 31, 2022 and 2021	5
Condensed Consolidated Statements of Stockholders’ Equity – Three Months Ended March 31, 2022 and 2021	6
Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 2022 and 2021	7
Notes to the Condensed Consolidated Financial Statements	8

QHSLab, Inc.

Condensed Consolidated Balance Sheets

		March 31, 2022			December 31, 2021
	(Unaudited)
Assets
Current Assets:
Cash and cash equivalents	$	155,557		$	286,855
Accounts receivable		96,093			70,474
Inventory		73,153			65,740
Prepaid expenses and other current assets		71,888			22,713
Total current assets		396,691			445,782
Non-current assets:
Capitalized software development costs		223,390			186,271
Intangible assets, net		1,558,416			1,576,444
Total assets	$	2,178,497		$	2,208,497
Liabilities and Stockholders’ Equity
Current Liabilities:
Accounts payable	$	33,045		$	20,370
Other current liabilities		46,328			58,615
Loans payable, current portion		342,239			253,865
Convertible notes payable, current portion		613,954			542,104
Total current liabilities		1,035,566			874,954
Non-current liabilities:
Accrued interest expenses		8,986			6,521
Loans payable, non-current portion		357,834			402,956
Convertible notes payable, non-current portion		100,000			100,000
Total non-current liabilities		466,820			509,477
Total liabilities		1,502,386			1,384,431

Commitment and contingencies (Note 12)

Stockholders’ Equity:

Preferred stock Series A, 10,000,000 shares authorized, $0.0001 par value; 1,080,092 shares issued and outstanding		108			108
Preferred stock Series A-2, $0.0001 par value; 2,644,424 shares issued and outstanding		264			264
Preferred stock
Common stock, 900,000,000 shares authorized, $0.0001 par value; 8,815,508 and 8,756,093 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively		882			876
Unearned stock compensation		(3,484	)		(6,968	)
Additional paid-in capital		3,387,540			3,348,681
Accumulated deficit		(2,709,199	)		(2,518,895	)
Total stockholders’ equity		676,111			824,066
Total liabilities and stockholders’ equity	$	2,178,497		$	2,208,497

See accompanying notes to the unaudited condensed consolidated financial statements.

QHSLab, Inc.

Condensed Consolidated Statements of Operations

	Three Months Ended			Three Months Ended
	March 31, 2022			March 31, 2021
	(Unaudited)			(Unaudited)
Revenue	$	355,330		$	304,336

Cost of revenue		166,642			170,757

Gross profit		188,688			133,579

Operating Expenses:
Sales and marketing		113,294			111,688
General and administrative		89,514			70,127
Research and development		28,979			28,021
Amortization		18,028			-
Total Operating Expenses		249,815			209,836

Net operating loss		(61,127	)		(76,257	)

Interest expense		127,157			10,429
Loss on extinguishment of debt		2,020			-
Net loss	$	(190,304	)	$	(86,686	)

Basic and diluted net loss per share	$	(0.02	)	$	(0.01	)

Weighted average shares outstanding (basic and diluted)		8,779,859			6,833,261

See accompanying notes to the unaudited condensed consolidated financial statements.

QHSLab, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)


	Preferred Stock- Series A				Preferred Stock - Series A-2				Common Stock						Unearned Stock			Additional Paid-In		Accumulated			Total Stockholders’ Equity
	Shares				Shares				Shares			Amount			Compensation			Capital		Deficit			(Deficit)
Balance at January 1, 2022		1,080,092	$	108		2,644,424	$	264		8,756,093		$	876		$	(6,968	)	$	3,348,681	$	(2,518,895	)	$	824,066
Shares issued for services		-		-		-		-		-			-			3,484			-		-			3,484
Conversion of notes payable		-		-		-		-		59,415			6			-			27,919		-			27,925
Warrants issued with conversion of notes payable		-		-		-		-		-			-			-			2,020		-			2,020
Stock-based compensation expense		-		-		-		-		-			-			-			8,920		-			8,920
Net loss		-		-		-		-		-			-			-			-		(190,304	)		(190,304	)
Balance at March 31, 2022		1,080,092	$	108		2,644,424	$	264		8,815,508		$	882		$	(3,484	)	$	3,387,540	$	(2,709,199	)	$	676,111

Balance at January 1, 2021		1,080,092	$	108		-	$	-		6,562,735		$	656		$	(124,479	)	$	1,264,108	$	(1,748,719	)	$	(608,326	)
Shares issued for services		-		-		-		-		150,000			15			(89,419	)		89,985		-			581
Conversion of notes payable		-		-		-		-		496,718			50			-			194,161		-			194,211
Cancellation of shares		-		-		-		-		(100,000	)		(10	)		-			10		-			-
Amortization of unearned compensation		-		-		-		-		-			-			67,812			-		-			67,812
Stock-based compensation expense		-		-		-		-		-			-			-			8,920		-			8,920
Net loss		-		-		-		-		-			-			-			-		(86,686	)		(86,686	)
Balance at March 31, 2021		1,080,092	$	108		-	$	-		7,109,453		$	711		$	(146,086	)	$	1,557,184	$	(1,835,405	)	$	(423,488	)

See accompanying notes to the unaudited condensed consolidated financial statements.

QHSLab, Inc.

Condensed Consolidated Statements of Cash Flows

	For the Three Months Ended			For the Three Months Ended
	March 31, 2022			March 31, 2021

Operating activities
Net loss	$	(190,304	)	$	(86,686	)
Adjustments to reconcile net loss to net cash from operating activities:
Amortization		18,028			-
Amortization of debt and warrant issuance costs		96,850			-
Stock-based compensation		8,920			8,920
Shares issued for services		3,484			68,393
Loss on extinguishment of debt		2,020			-
Changes in operating assets and liabilities:
Increase in accounts receivable		(25,619	)		(9,975	)
(Increase)/decrease in inventory		(7,413	)		38,561
Increase in prepaid expenses and other current assets		(49,175	)		(1,088	)
Increase/(decrease) in accounts payable		12,675			(67,556	)
Decrease in other current liabilities		(14,257	)		(433	)
Increase in accrued interest		7,360			16,972
Cash flows from operating activities		(137,431	)		(32,892	)

Investing activities:
Capitalized software		(37,119	)		(26,882	)
Cash flows from investing activities		(37,119	)		(26,882	)

Financing activities:
Proceeds of loan borrowings		128,500			-
Repayments of loan borrowings		(85,248	)		-
Cash flows from financing activities		43,252			-

Change in cash		(131,298	)		(59,774	)
Cash and cash equivalents – beginning of year		286,855			94,342
Cash and cash equivalents - end of period	$	155,557		$	34,568

Supplemental disclosures of cash flow activity:
Cash paid for interest	$	18,519		$	21
Cash paid for taxes	$	-		$	-
Supplemental noncash investing and financing activity:
Debt and accrued interest converted to shares of common stock	$	27,925		$	194,211

See accompanying notes to the unaudited condensed consolidated financial statements.

QHSLab, Inc.

Notes to the Condensed Consolidated Financial Statements

Note 1. The Company

QHSLab, Inc. (f/k/a USA Equities Corp.) (the “Company”, or the “Registrant”) was incorporated in Delaware on September 1, 1983. In 2015, the Company changed its name to USA Equities Corp. On September 23, 2021, the Company changed its state of incorporation from Delaware to Nevada as a result of a merger with and into its newly formed wholly-owned subsidiary, USA Equities Corp., a Nevada corporation (“USA Equities Nevada”), the surviving entity pursuant to an Agreement and Plan of Merger. The reincorporation was approved by the stockholders of the Company and USA Equities Nevada is deemed to be the successor to USA Equities Corp, the Delaware corporation. On April 19, 2022, the Company changed its name to QHSLab, Inc.

The Company is a medical device technology and software as a service (“SaaS”) company focused on enabling primary care physicians (“PCP’s”) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.

Note 2. Going Concern

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred losses since inception, has negative operational cash flows and began recognizing revenues in the fourth quarter of fiscal 2020. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The continuation of the Company’s business is dependent upon its ability to achieve profitability and positive cash flows and, pending such achievement, future issuances of equity or other financings to fund ongoing operations. However, access to such funding may not be available on commercially reasonable terms, if at all. These condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note 3. Basis of Presentation

The condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring accruals, necessary for a fair statement of financial position, results of operations, and cash flows. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and the accompanying notes included in our Annual Report on Form 10- K for the year ended December 31, 2021.

The accounting policies are described in the “Notes to the Consolidated Financial Statements” in the 2021 Annual Report on Form 10-K and updated, as necessary, in this Form 10-Q. The year-end balance sheet data presented for comparative purposes was derived from audited consolidated financial statements but does not include all disclosures required by accounting principles generally accepted in the United States. The results of operations for the three months ended March 31, 2022 and 2021 are not necessarily indicative of the operating results for the full year or for any other subsequent interim period.

Reclassifications

Certain reclassifications were made to the prior condensed consolidated financial statements to conform to the current period presentation. There was no change to the previously reported net loss.

Risks Related to COVID-19 Pandemic

The COVID-19 pandemic is affecting the United States and global economies and may affect the Company’s operations and those of third parties on which the Company relies. While the potential economic impact brought by, and the duration of, the COVID-19 pandemic is difficult to assess or predict, the impact of the COVID-19 pandemic could negatively impact the Company’s short-term and long-term liquidity. The ultimate impact of the COVID-19 pandemic is highly uncertain and the Company does not yet know the full extent of potential impacts on its business, financing or global economy as a whole. However, these effects could have a material impact on the Company’s liquidity, capital resources and operations.

Accounting Policies

Use of Estimates: The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.

Principles of Consolidation: The condensed consolidated financial statements include the accounts of QHSLab, Inc. and its wholly owned subsidiaries USAQ Corporation, Inc., and Medical Practice Income, Inc. All significant inter-company balances and transactions have been eliminated.

Cash and Cash Equivalents: For financial statement presentation purposes, the Company considers those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents.

Accounts Receivable: The Company extends unsecured credit to its customers on a regular basis. Management monitors the payments on outstanding balances and will establish a reserve for uncollectible balances as necessary based on experience.

Inventories: Inventories are stated at the lower of cost or estimated net realizable value, on a first-in, first-out, or FIFO, basis. The Company uses actual costs to determine its cost basis for inventories. Inventories consist of only finished goods.

Capitalized Software Development Costs: Software development costs for internal-use software are accounted for in accordance with Accounting Standards Codification (“ASC”) 350-40, Internal-Use Software. Development costs that are incurred during the application development stage begin to be capitalized when two criteria are met: (i) the preliminary project stage is completed and (ii) it is probable that the software will be completed and used for its intended function. Capitalization ceases once the software is substantially complete and ready for its intended use. Costs incurred during the preliminary project stage of software development and post-implementation operating stages are expensed as incurred. Amortization is calculated on a straight-line basis over the remaining economic life of the software (typically three to five years) and will be included in the operating expenses on the condensed consolidated Statements of Operations once amortization begins.

The estimated useful lives of software are reviewed at least annually and will be tested for impairment whenever events or changes in circumstances occur that could impact the recoverability of the assets.

Capitalized software development costs for internal-use software totaled $223,390 as of March 31, 2022 and $186,271 as of December 31, 2021. The software application is still in development with costs continuing to be capitalized and no amortization expense being recognized during the periods ended March 31, 2022 and December 31, 2021. There were no impairments recognized during the periods ended March 31, 2022 and December 31, 2021.

Intangible Assets: Intangible assets represent the value the Company paid to acquire assets including a trademark, patent and web domain on June 23, 2021. The allocation of the purchase price to each of these assets was determined based on ASC 805-50-30, Business Combination, Related Issues, Initial Measurement. These assets are accounted for in accordance with ASC 350-30, Intangibles, General Intangibles Other Than Goodwill. The cost of the assets is amortized over the remaining useful life of the assets as follows:

U.S. Method Patent	13.4 years

Web Domain	Indefinite life

Trademark	Indefinite life

The estimated useful lives and carrying value of the assets are reviewed at least annually or whenever events or circumstances may result in an impact to the value of the assets.

Convertible Notes Payable: The Company accounts for convertible notes deemed conventional and conversion options embedded in non-conventional convertible notes which qualify as equity under ASC 815, Derivatives and Hedging, in accordance with the provisions of ASC 470-20, Debt with Conversion and Other Options, which provides guidance on accounting for convertible securities with beneficial conversion features. ASC 470-20 addresses classification determination for specific obligations, such as short-term obligations expected to be refinanced on a long-term basis, due-on-demand loan arrangements, callable debt, sales of future revenue, increasing rate debt, debt that includes covenants, revolving credit agreements subject to lock-box arrangements and subjective acceleration clauses. Accordingly, the Company records, as a discount to convertible notes, the intrinsic value of such conversion options based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt.

Revenue Recognition: Pursuant to ASC Topic 606, Revenue from Contracts with Customers, or ASC 606, the Company recognizes revenue upon transfer of control of goods, in an amount that reflects the consideration that is expected to be received in exchange for those goods. The Company does not allow for the return of products and therefore does not establish an allowance for returns.

To determine the revenue to be recognized for transactions that the Company determines are within the scope of ASC 606, the Company follows the established five-step framework as follows:

	(i)	identify the contract(s) with a customer;
	(ii)	identify the performance obligations in the contract(s);
	(iii)	determine the transaction price;
	(iv)	allocate the transaction price to the performance obligations in the contract(s); and
	(v)	recognize revenue when (or as) the Company satisfies a performance obligation.

The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians. Revenue is recognized once the Company satisfies its performance obligation which occurs at the point in time when title and possession of products have transitioned to the customer, typically upon delivery of the products.

The Company includes shipping and handling fees billed to customers in revenue.

There are several practical expedients and exemptions allowed under ASC 606 that impact timing of revenue recognition and disclosures. The Company elected to treat similar contracts as a portfolio of contracts, as allowed under ASC 606. The contracts that fall within the portfolio have the same terms and management has the expectation that the result will not be materially different from the consideration of each individual contract.

Research and Development: Research and development expense is primarily related to developing and improving methods related to the Company’s Software as a Service (SaaS) platform. Research and development expenses are expensed when incurred. For the three months ended March 31, 2022 and 2021, there were $28,979 and $28,021 of research and development expenses incurred, respectively.

Stock-based Compensation: The Company applies the fair value method of ASC 718, Share Based Payment, in accounting for its stock-based compensation. The standard states that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values stock-based compensation at the market price for the Company’s common stock and other pertinent factors at the grant date.

Earnings Per Common Share: Basic net loss per share is computed using the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed using the weighted average number of common and dilutive equivalent shares outstanding during the period. Dilutive common equivalent shares consist of options and warrants to purchase common stock (only if those options and warrants are exercisable and at prices below the average share price for the period) and shares issuable upon the conversion of issued and outstanding preferred stock. Due to the net losses reported, dilutive common equivalent shares were excluded from the computation of diluted loss per share, as inclusion would be anti-dilutive for the periods presented. There were no common equivalent shares required to be added to the basic weighted average shares outstanding to arrive at diluted weighted average shares outstanding as of March 31, 2022 or 2021.

Income Taxes: The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized.

The Company has net operating losses of $2,709,199 which begin to expire in 2027. Future utilization of currently generated federal and state NOL and tax credit carry forwards may be subject to a substantial annual limitation due to the ownership change limitations. The annual limitation may result in the expiration of NOL and tax credit carry-forwards before full utilization.

Recently Issued Accounting Standards

In August 2020, the Financial Accounts Standards Board (“FASB”) issued Accounting Standards Updates (“ASU”) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40), or ASU 2020-06. The updated guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. Consequently, more convertible debt instruments will be reported as single liability instruments with no separate accounting for embedded conversion features. The ASU 2020-06 also removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. In addition, ASU 2020-06 also simplifies the diluted net income per share calculation in certain areas. The Company adopted the provisions of ASU 2020-06 using a modified retrospective approach, which resulted in no cumulative effect adjustment to stockholders’ deficit as of January 1, 2021.

This Quarterly Report on Form 10-Q does not discuss recent pronouncements that are not anticipated to have a current and/or future impact on or are unrelated to the Company’s financial condition, results of operations, cash flows or disclosures.

Note 4. Capitalized Software and Intangible Assets

Non-current assets consist of the following at March 31, 2022 and December 31, 2021:

Schedule of Intangible Assets

	Estimated Useful Life (in years)		March 31, 2022			December 31, 2021
Capitalized Software		TBD	$	223,390		$	186,271
Intangible Assets:
U.S. Method Patent		13.4	$	967,500		$	967,500
Web Domain		N/A		161,250			161,250
Trademark		N/A		483,750			483,750
Total Intangible Assets			$	1,612,500		$	1,612,500
Accumulated amortization				(54,084	)		(36,056	)
Intangible assets, net			$	1,558,416		$	1,576,444

Capitalized software represents the development costs for internal-use software. The software application is still in development with costs continuing to be capitalized and no amortization expense being recognized yet. Capitalization will cease and amortization will begin once development is substantially complete. The Capitalized software costs will be amortized over the estimated life of the software. There were no impairments recognized during the periods ended March 31, 2022 and December 31, 2021.

The intangible assets represent the value the Company paid to acquire the trademark “AllergiEnd”, the web domain “AllergiEnd.com” along with the U.S. Method Patent registration relating to the allergy testing kit and related materials the Company distributes to physician clients. The Company acquired the intangible assets from MedScience Research Group as of June 23, 2021 for total consideration of $1,612,500 which was financed through a combination of restricted stock and a promissory note. The allocation of the purchase price to each of these assets was determined based on ASC 805-50-30, Business Combination, Related Issues, Initial Measurement. The assets are being amortized over their useful lives beginning July 1, 2021. The Trademark and Web Domain are determined to have an indefinite life and will be tested annually for impairment in accordance with ASC 350-30-35, Intangibles, General Intangibles Other Than Goodwill. There was $18,028 of amortization expense during the quarter ended March 31, 2022 and no amortization expense during the quarter ended March 31, 2021.

Note 5. Loans Payable

On June 23, 2021, the Company entered into a purchase agreement to acquire certain assets from MedScience Research Group, Inc (“MedScience”) (See Note 4 for additional information). As part of that purchase agreement, the Company issued a Promissory Note with a principal sum of $750,000. The principal, along with associated interest, are being paid in 36 equal monthly installments that began in July 2021. The principal balance of the loan is divided between current and long-term liabilities on the Company’s condensed consolidated balance sheets. The combined principal due along with accrued interest as of March 31, 2022 is $586,716 and as of December 31, 2021 was $644,158.

On March 2, 2022, the Company entered into a fixed-fee short-term loan with its merchant bank and received $128,500 in loan proceeds. The loan payable, which is split between current and long-term liabilities on the Company’s condensed consolidated balance sheets, is due in August 2023. The loan is repaid by the merchant bank withholding an agreed-upon percentage of payments they process on behalf of the Company with a minimum of $16,305 paid every 60 days. As of March 31, 2022, the loan balance is $117,117. The prior fixed-fee short-term loan with the same merchant bank had a balance of $16,793 as of December 31, 2021 and was paid in full during the first quarter 2022.

Note 6. Convertible Notes Payable

Convertible notes payable at March 31, 2022 and December 31, 2021, consist of the following:

Schedule of Convertible Notes Payable

	March 31, 2022			December 31, 2021
Note 1 – Accredited investors	$	-		$	25,000
Note 2 – Shareholder		100,000			100,000
Note 3 – Mercer Note		756,000			756,000
Total		856,000			881,000
Debt discount and issuance costs		(142,046	)		(238,896	)
Total convertible notes payable		713,954			642,104
Less: current portion		613,954			542,104
Non-current portion	$	100,000		$	100,000

Note 1 – Effective December 23, 2020, the Company issued a Convertible Promissory Note in the principal amount of $25,000 to a shareholder (Note 1). This Note was issued under a subscription agreement dated September 25, 2020. As of March 31, 2022 and December 31, 2021, this note had $0 and $2,555, respectively, of accrued interest. On February 23, 2022 the shareholder elected to convert the outstanding principal of $25,000 along with accrued interest into 59,415 shares of common stock at a price of $0.47 per share. Additionally, the shareholder received warrants exercisable for two years to purchase 14,854 common shares at $0.705 per share.

Note 2 – Effective May 7, 2021, the Company issued a Convertible Promissory Note in the principal amount of $100,000 to a shareholder (Note 2). The Note bears interest at the rate of 10% per annum and matures on September 30, 2022 (the “Maturity Date”) at which date all outstanding principal and accrued and unpaid interest are due and payable. The Company may satisfy the Note upon maturity or Default, as defined, by the issuance of common shares at a conversion price equal to the greater of a 25% discount to the 15-day average market price of the Company’s common stock or $0.50. The principal and interest accrued are convertible at any time through the maturity date of September 30, 2022 at the option of the holder using the same conversion calculation. As of March 31, 2022 and December 31, 2021, this note had $8,986 and $6,521, respectively, of accrued interest.

Note 3 – Effective August 10, 2021, the Company entered into a Securities Purchase Agreement with an accredited investor pursuant to which it issued to the investor an Original Issue Discount Secured Convertible Promissory Note (the “Note”) in the principal amount of $806,000 and warrants to purchase 930,000 shares of the Company’s common stock for aggregate consideration of $750,000. In addition, pursuant to the Purchase Agreement the Company entered into a Registration Rights Agreement with the investor.

The principal amount of the Note and all interest accrued thereon is payable on August 10, 2022, and are secured by a lien on substantially all of the Company’s assets. The Note provides for interest at the rate of 5% per annum, payable at maturity, and is convertible into common stock at a price of $0.65 per share. In addition to customary anti-dilution adjustments upon the occurrence of certain corporate events, the Note provides, subject to certain limited exceptions, that if we issue any common stock or common stock equivalents, as defined in the Note, at a per share price lower than the conversion price then in effect, the conversion price will be reduced to the per share price at which such stock or common stock equivalents were sold. The conversion price of the Note had been subject to a potential decrease if the average closing price of the Company’s common stock during any ten consecutive trading days beginning September 16, 2021, and ending on November 15, 2021, was below $0.65. As the trading price of the common stock has not been below $0.65 since September 21, 2021, this provision is no longer operative.

On November 11, 2021, Mercer Street Global Opportunity Fund, LLC, converted $50,000 of the principal amount of the $806,000 Secured Convertible Promissory Note issued August 10, 2021, into 76,923 shares of the Company’s common stock at a price of $0.65 per share.

The 930,000 Warrants are initially exercisable for a period of three years at a price of $1.25 per share, subject to customary anti-dilution adjustments upon the occurrence of certain corporate events as set forth in the Warrant. The shares issuable upon conversion of the Note and exercise of the Warrants are to be registered under the Securities Act of 1933, as amended, for resale by the investor as provided in the Registration Rights Agreement. The Warrants may be exercised by means of a “cashless exercise” if at any time the shares issuable upon exercise of the Warrant are not covered by an effective registration statement.

The Company accounts for the allocation of its issuance costs to its Warrants in accordance with ASC 470-20, Debt with Conversion and Other Options. Under this guidance, if debt or stock is issued with detachable warrants, the proceeds need to be allocated to the two instruments using either the fair value method, the relative fair value method, or the residual value method. The Company used the relative fair value at the time of issuance to allocate the value received between the convertible note and the warrants.

The Company estimated the fair value of the Warrants utilizing the Black-Scholes pricing model, which is dependent upon several assumptions such as the expected term of the Warrants, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected term and expected dividend yield rate over the expected term. The Company believes this valuation methodology is appropriate for estimating the fair value of warrants. The value allocated to the relative fair value of the Warrants was recorded as debt issuance costs and additional paid in capital.

The principal, net of the original issue discount and debt issuance costs, including the allocated relative fair value of the Warrants, which are being recognized over the life of the Note, along with associated interest, is recorded with current liabilities on the Company’s condensed consolidated balance sheets. As of March 31, 2022, this Note had $24,767 of accrued interest, total unamortized debt issuance costs of $121,794, including the Warrant value, and the remaining discount of $20,252. As of December 31, 2021, this note had $15,446 of accrued interest, total unamortized debt issuance costs of $204,835, including the Warrant value, and the remaining discount of $34,060.

Note 7. Preferred Stock

Series A Preferred Stock

The shares of Series A Preferred Stock have a stated value of $0.25 per share and are initially convertible into shares of common stock at a price of $0.05 per share (subject to adjustment upon the occurrence of certain events). The Series A Preferred Stock does not accrue dividends and ranks prior to the common stock upon a liquidation of the Company. The Series A Preferred Stock votes on all matters brought before the shareholders together with the Common stock as a single class and each share of Series A Preferred Stock has a number of votes, initially 5, equal to the number of shares of preferred stock into which it is convertible as of the record date for any vote.

Series A-2 Preferred Stock

On December 30, 2021, the Company issued 2,644,424 of the Company’s Series A-2 Convertible Preferred Shares to its principal shareholder in satisfaction of multiple outstanding convertible promissory notes with initial principal amounts totaling $286,078 together with all interest accrued thereon.

The rights of holders of the Company’s common stock with respect to the payment of dividends and upon liquidation are junior in right of payment to holders of the Series A-2 Convertible Preferred Shares. The rights of the holders of the Company’s Series A-2 Preferred Shares are pari passu to the rights of the holders of the Company’s Series A Preferred Shares currently outstanding.

Holders of the Series A-2 Convertible Preferred Stock will vote on an as converted basis with the holders of the Company’s common stock and Series A Preferred Shares as to all matters to be voted on by the holders of the common stock. Each Series A-2 Preferred Share shall be entitled to a number of votes equal to five times the number of shares of common stock into which it is then convertible on the applicable record date.

Note 8. Loss Per Common Share

The Company calculates net loss per common share in accordance with ASC 260, Earnings Per Share. Basic and diluted net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding during the period. The Company’s potentially dilutive shares, which include shares issuable upon exercise or conversion of outstanding common stock options, common stock warrants, and convertible debt have not been included in the computation of diluted net loss per share for the quarters ended March 31, 2022 and 2021 as the result would be anti-dilutive.

	2022		2021
	Three Months Ended March 31,
	2022		2021
Stock options		1,100,000		650,000
Stock warrants		1,026,647		-
Total shares excluded from calculation		2,126,647		650,000

Note 9. Stock-based Compensation

During the three-month periods ended March 31, 2022 and 2021, there was $8,920 in stock-based compensation associated with stock options included in Research and development expense. Additionally, during the same periods there was expense associated with shares issued for services. The following table shows how the expenses associated with shares issued for services were classified in the condensed consolidated statements of operations during the respective periods.

	2022		2021
	Three Months Ended March 31,
	2022		2021
Research and development	$	-	$	21,625
Sales and marketing		-		29,187
General and administrative		3,484		17,581
Total expense – shares issued for services	$	3,484	$	68,393

During the three months ended March 31, 2021 there were 450,000 options granted to certain scientific and business advisors (“Advisors”) with a weighted-average exercise price of $0.65. The options vest in equal annual installments over three years beginning in April 2021 and expire five years after grant date. There were no options exercised, forfeited or cancelled during the period. During the three months ended March 31, 2022 there were no options granted.

As of March 31, 2022, there was $27,164 of unrecognized compensation related to 1,100,000 outstanding options which is expected to be recognized over a weighted-average period of 11 months. The options are being expensed over the vesting period for each Advisor. The weighted-average grant date fair value for options granted during the three months ended March 31, 2021 was $0.12.

The fair value of all options granted is determined using the Black-Scholes option-pricing model. The following weighted-average assumptions were used:

	Three Months Ended March 31, 2022		Three Months Ended March 31, 2021
Risk-free interest rate		N/A		0.21	%
Expected life of the options		N/A		3.5 years
Expected volatility of the underlying stock		N/A		76.3	%
Expected dividend rate		N/A		0	%

The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected term of the options. The expected life of the options is based on the option term. Due to the Company’s limited historical data, the expected volatility is calculated based upon the historical volatility of comparable companies whose share prices are publicly available for a sufficient period of time. The dividend rate is based on the Company never paying or having the intent to pay any cash dividends.

Options outstanding at March 31, 2022 consist of:

Date Issued	Number Outstanding		Number Exercisable		Exercise Price		Expiration Date
March 12, 2020		500,000		333,333	$	0.40	March 12, 2025
June 27, 2020		150,000		100,000	$	0.40	June 27, 2025
January 1, 2021		450,000		150,000	$	0.65	December 31, 2025
Total		1,100,000		583,333

Warrants outstanding at March 31, 2022 consist of:

Date Issued	Number Outstanding		Number Exercisable		Exercise Price		Expiration Date
March 16, 2021		15,900		15,900	$	0.75	March 15, 2023
May 7, 2021		53,704		53,704	$	0.74	May 6, 2023
June 17, 2021		12,189		12,189	$	0.83	June 16, 2023
August 10, 2021		930,000		930,000	$	1.25	August 9, 2024
February 23, 2022		14,854		14,854	$	0.705	February 22, 2024
Total		1,026,647		1,026,647

Note 10. Related Party Transactions

Convertible notes payable, related party: See Note 6.

Note 11. Income Taxes

For the three month period ended March 31, 2022 and the year ended December 31, 2021, the Company did not record a tax provision as the Company did not earn any taxable income in either period and maintains a full valuation allowance against its net deferred tax assets.

Note 12. Commitments and Contingencies

On February 9, 2021, the Company entered into a Receivables Purchase and Security Agreement (“Factoring Agreement”) with a Factoring Company. The Factoring Agreement has an initial term of one year and, in accordance with its terms, has been renewed for an additional year.

Under the terms of the agreement, designated receivables are sold for periodic advances of up to $150,000. The Factoring Company retains a reserve of 10% of purchased receivables with the balance available to the Company. Factoring fees begin at 1.8% for the first 30 days a purchased invoice is outstanding and increase the longer an invoice remains outstanding. After 90 days, the Factoring Company has the right to assign the invoice back to the Company. The Factoring Agreement includes minimum average monthly volumes.

As of March 31, 2022, the balance of outstanding invoices that the Factoring Company may assign back to the Company if not collected within 90 days is included in the Company’s Accounts Receivable balance with the amounts received, net of reserves held, included with other current liabilities on the condensed consolidated balance sheets. The net amount included in other current liabilities is $10,334 and $25,420 as of March 31, 2022 and December 31, 2021, respectively.

There are no pending or threatened legal proceedings as of March 31, 2022. The Company has no non-cancellable operating leases.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Overview

We are a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCP’s) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. In some cases, the products we provide our physician clients will enable them to diagnose and treat patients with chronic diseases which they historically have referred to specialists, allowing them to increase their practice revenue. As part of our mission, we are providing PCP’s with the software, training and devices necessary to allow them to treat their patients using value-based healthcare, informatics and algorithmic personalized medicine, including digital therapeutics. Our virtual and point of care solutions also support remote patient monitoring, to address chronic care and preventive medicine and are reimbursable to the medical practice.

In November 2020, we began shipping AllergiEnd® diagnostic related products and immunotherapy treatments to PCPs in response to their requests based upon courses of treatment recommended for their patients building on the capabilities of QHSLab, our primary SaaS tool. The Company’s revenue generated from sales of AllergiEnd® products was $355,330 in the first quarter of 2022 compared to $304,336 for the same period 2021. Our PCPs generated approximately $5,000,000 in revenues utilizing our products during 2021, of which $3.8 million was the result of providing allergy diagnostic tests to patients and approximately $1.2 million was the result of providing allergen immunotherapy treatments.

In June 2021, we acquired the method patent, trademark and website associated with AllergiEnd®’s diagnostic and allergen immunotherapy product portfolio from MedScience Research Group, Inc. The acquisition of the AllergiEnd® assets provides us the opportunity to more fully integrate and leverage the product portfolio across our marketing platform, customer relationships and cost structure.

Based on the success of PCPs using our QHSLab allergy diagnostics combined with the products acquired from MedScience, we intend to increase our revenues by charging physicians a monthly subscription fee for the use of QHSLab and soliciting additional PCPs to increase their revenues by using our proven revenue generating QHSLab and AllergiEnd® line of products. We also plan to introduce additional point of care diagnostics and treatments, and digital medicine programs that PCPs can use and prescribe in their practices. In all cases, PCPs will be paid under existing government and private insurance programs, based upon analyses conducted utilizing QHSLab and treatments provided as a result of such analyses.

In addition to the direct sales and marketing efforts of our personnel, we engaged the University of Miami to launch and promote various continuing medical education activities to our target physician client audiences during 2021, and intend to replicate these programs during 2022. The Company has also engaged with Management Service Organizations (MSO), Independent Physician Associations (IPA’s) and Digital Marketing collaborations for joint marketing efforts and distribution. There are no assurances that these relationships will accelerate growth.

Recent Market Conditions

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic has significantly impacted economic conditions in the United States and throughout the world. The ultimate impact of the COVID-19 pandemic is highly uncertain and we do not yet know the full extent of potential impacts on our business, financing or the global economy as a whole. However, these effects could have a material impact on our liquidity, capital resources and operations.

COVID-19 has accelerated both the healthcare provider and patient acceptance of virtual care technologies. Many patients are now open to telemedicine, which is excellent, but it’s not the complete solution, as it still requires a physician’s direct involvement. Regulators and insurance companies recognize what health care technologists have been saying for nearly 15 years, which is that most chronic conditions are better managed with more frequent and short encounters than infrequent visits. Health insurers are beginning to recognize that AI enabled digital medicine technologies such as those provided through QHSLab can provide the necessary encounters to foster patient compliance in between visits to a physician.

Our ability to operate profitably is determined by our ability to generate revenues from the licensing of our QHSLab and the sale of diagnostic related products and treatment protocols and the provision of services through our QHSLab. Currently, we are generating revenues from the sale of AllergiEnd® diagnostic related products and immunotherapy treatments. Our ability to generate a profit from these sales is determined by our ability to increase the number of physicians using these products. We will continue to upgrade QHSLab in an effort to increase the number of products sold based upon the services it can provide and before which we are able to charge a fee for its use.

While our revenues are largely determined by the volume of product delivered and the prices at which such products are sold, our costs are determined by a number of factors. The principal factors impacting our costs are the cost of improvements to QHSLab, the costs of products sold to PCPs, marketing expenses to recruit new PCPs and introduce new products and financing costs. As our business grows, these costs should be spread over a wider base of PCPs leading to a reduction in costs per sale and, helping to increase our gross margin.

Results of Operations during the three months ended March 31, 2022 as compared to the three months ended March 31, 2021

Revenues

During the fourth quarter of 2020 we began to sell AllergiEnd® Allergy Diagnostics and Allergen Immunotherapy treatments to physicians. These sales have continued to grow and for the three months ended March 31, 2022, we generated revenues of $355,330 compared to $304,336 in the comparable period of 2021. The revenue increase for the three months ended March 31, 2022 was primarily driven by sales of Allergy Diagnostic Kits of $203,594, an increase of $16,187 compared to the three months ended March 31, 2021. Immunotherapy Treatment services increased $34,153 to $142,006 during the same periods. The Company continues to expand its roll-out of its product lines increasing its customer base.

Our revenues consisted of the following:

	For the Three Months Ended
	March 31,
	2022		2021
Allergy Diagnostic Kit Sales	$	203,594	$	187,407
Immunotherapy Treatment Sales		142,006		107,853
Shipping and handling		9,730		9,076
Total revenue	$	355,330	$	304,336

Cost of Revenues and Gross Profit

Cost of revenues consists of the cost of the AllergiEnd® test kits and allergen immunotherapy pharmacy prepared treatment sets, shipping costs to our customers as well as labor expenses directly related to product sales.

For the three months ended March 31, 2022 and 2021, cost of revenues was $166,642 and $170,757, respectively.

The Company generated a gross profit of $188,688 during the three months ended March 31, 2022 compared to $133,579 for the three months ended March 31, 2021. Gross margin increased from 43.9% gross margin during the three months ended March 31, 2021 to 53.1% during the three months ended March 31, 2022. The increase in gross margin was primarily attributable to the larger base of sales as well as changes in the product mix.

We are introducing new products at an early stage in our development cycle and the margins earned may vary significantly between periods, customers and products due to the learning process, customer negotiating strengths, and product mix.

Sales and Marketing

Selling and marketing expenses consist primarily of costs associated with selling and marketing our products to PCP’s, principally ongoing sales efforts to recruit new PCP’s and maintain our relationships with PCP’s already using our software and products. These expenses include employee compensation and costs of consultants. For the three months ended March 31, 2022, selling and marketing expenses totaled $113,294 compared to $111,688 for the three months ended March 31, 2021.

We expect our selling and marketing expenses to increase as we seek to build our customer base and launch additional products. Nevertheless, if we are successful in onboarding a sufficient number of PCP’s and maintaining our relationships with these PCP’s once they begin to distribute our products, selling and marketing expenses could decrease as a percentage of revenues, though we may increase our marketing efforts as funds become available.

General and Administrative

General and administrative expenses consist primarily of costs associated with operating a business including accounting, legal and management consulting fees.

For the three months ended March 31, 2022, general and administrative expenses totaled $89,514, an increase of $19,387, compared to $70,127 for the three months ended March 31, 2021. The increase is primarily due to increased fees for investor relations and accounting-related services. Additionally, the Company incurred higher expenses associated with processing payments on sales.

Research and Development

Research and development (“R&D”) includes expenses incurred in connection with the research and development of our medical device technology solution, including software development. R&D costs are expensed as they are incurred.

For the three months ended March 31, 2022, R&D expenses totaled $28,979 which is a slight increase of $958 compared to $28,021 for the three months ended March 31, 2021. The increase is primarily due to costs associated with R&D contractors.

We expect that our R&D expenses will increase as we invest in and expand our operations and further develop new products and services as part of the Company’s growth strategy.

Other Expense

For the three months ended March 31, 2022, interest expense increased by $116,728 to $127,157 from $10,429 for the three months ended March 31, 2021. The increase was due to higher debt balances, primarily related to the purchase of certain assets related to our AllergiEnd® products, at March 31, 2022 compared to March 31, 2021. Interest expense during the first quarter of 2022 included interest on the outstanding debt as well as the amortization of debt issuance costs including legal fees and warrants issued in connection with the note issued to purchase certain assets related to our AllergiEnd® products. The amortization of those costs totaled $83,041, or 65% of the interest expense during the quarter. Interest expense during the first quarter of 2021 was all related to interest on outstanding debt balances, primarily outstanding convertible notes payable.

Liquidity and Capital Resources

Liquidity is a measure of a company’s ability to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. On March 31, 2022, we had current assets totaling $396,691, including $155,557 of cash, $96,093 of accounts receivable, $73,153 of inventory, and $71,888 related to prepaid expenses and other current assets. At such date we had total current liabilities of $1,035,566 consisting of $33,045 in accounts payable, $46,328 in other current liabilities and $956,193 representing the current portions of outstanding loans and convertible notes. Our long-term liabilities balance of $466,820 consisted of convertible notes totaling $100,000 and $357,834 associated with the long-term portion of loans payable, and accrued interest expenses of $8,986.

On December 31, 2021, we had current assets totaling $445,782, including $286,855 of cash, $70,474 of accounts receivable, $65,740 of inventory, and $22,713 related to prepaid expenses and other current assets. At such date we had total current liabilities of $874,954 consisting of $20,370 in accounts payable, $58,615 in other current liabilities and $795,969 representing the current portions of outstanding loans and convertible notes payable. Our long-term liabilities balance of $509,477 consisted of convertible notes totaling $100,000 and $402,956 associated with the long-term portion of loans payable, and accrued interest expenses of $6,521.

During the third quarter of 2021, we issued a promissory note of $750,000 in connection with our acquisition of certain assets related to our AllergiEnd® products and an Original Issue Discount Secured Convertible Promissory Note in the principal amount of $806,000 (the “OID Note”) along with warrants to purchase 930,000 shares of our common stock (the “Warrants”) for aggregate consideration of $750,000. The acquisition of the assets related to our AllergiEnd® products should enable us to increase our margins on the sale of these products enabling us to satisfy the $750,000 Note. The net proceeds of the OID Note primarily have been used to increase our sales and marketing efforts.

The changes in accounts receivable, inventory and accounts payable primarily relate to sales of AllergiEnd® Products.

We used cash of $137,431 and $32,892 in operations during the quarters ended March 31, 2022 and 2021, respectively. We began to generate revenues in the fourth quarter of 2020. Nevertheless, we continued to generate negative cash flows which were financed primarily through our entry into a factoring agreement for our receivables, a loan from our credit card processor and other borrowings as we had done previously. As a result, we owed increased amounts to third parties discussed below.

Our convertible notes payable were reduced during the quarter ended March 31, 2022 as one note totaling $27,925 inclusive of accrued interest, was converted into 59,415 shares of our common stock and 14,854 warrants.

Although we are now generating revenues from the sale of our AllergiEnd® products we are likely to continue to require funds to support our operations and expand our marketing efforts for the immediate future. If our business continues to grow, we will seek to satisfy our cash needs by issuances of our equity securities or debt. In the past, we have had to rely on our principal shareholder to support our operations. More recently, we have borrowed money from third parties. If we are unable to obtain the funds we need from third parties, there is no assurance that any of our related parties will continue to provide such capital as may be necessary to continue our business or, if such funds are provided, that the agreed upon terms of any advance will be favorable to us.

The principal amount of the OID Note and all interest accrued thereon is payable on August 10, 2022, and is secured by a lien on substantially all of our assets. The OID Note provides for interest at the rate of 5% per annum, payable at maturity, and is convertible into shares of our common stock at a price of $0.65 per share. In addition to customary anti-dilution adjustments the OID Note provides, subject to certain limited exceptions, that if we issue common stock or common stock equivalents at a per share price lower than the conversion price then in effect, the conversion price will be reduced to the per share price at which such shares or common share equivalents are sold. The holder converted $50,000 of the principal amount into 76,923 shares of our common stock at a price of $0.65 per share. We have begun preliminary discussion with the holder of the OID Note regarding the need to extend the due date of the OID Note. There is no assurance we will come to an accommodation with the holder of the OID Note or refinance the OID Note by issuing debt or equity to a third party on terms that will be favorable to us. If we are unable to come to an agreement with the holder or refinance the OID Note with a third party, and the holder were to seek to exercise its rights under the Note, it could have a material adverse impact on the price of our common stock.

The Warrants are exercisable for a period of three years at a price of $1.25 per share, subject to customary anti-dilution adjustments. The shares issuable upon conversion of the OID Note and exercise of the Warrants have been registered under the Securities Act for resale by the Buyer.

Plan of Operation and Funding

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We had an accumulated deficit of $2,709,199 at March 31, 2022, generated net losses of $190,304 and $770,176 for the three months ended March 31, 2022 and the year ended December 31, 2021, respectively, and used cash of $137,431 and $354,738 in operations in these periods. Although we began to generate revenue during the fourth quarter of 2020, we anticipate that we will continue to generate negative cash flow for the immediate future. These factors, among others, raise substantial doubt about our ability to continue as a going concern for a reasonable period of time. Our continuation as a going concern is dependent upon our ability to obtain necessary equity or debt financing and ultimately from generating revenues and positive cash flow to continue operations. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

We expect that working capital requirements will continue to be funded through a combination of our existing funds, further issuances of securities and borrowings, and that we will remain highly leveraged as we seek to expand our business. Our working capital requirements are expected to increase in line with the growth of our business, as we incur marketing expenses and the cost of building an inventory. Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next twelve months. We have entered into a Receivables Purchase and Security Agreement providing us with up to $150,000 against certain accounts receivable but have no other lines of credit or other bank financing arrangements. Generally, we have financed our operations through the proceeds from private placements of equity and debt instruments and advances from our principal shareholder. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) developmental expenses associated with a start-up business and (ii) marketing expenses. We intend to finance these expenses by raising additional capital or, when available, borrowing additional funds. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.

Our ability to obtain funds through the issuance of debt or equity is dependent upon the state of the financial markets at such time as we may seek to raise funds. The state of the capital market markets may be adversely impacted by various risks and uncertainties, including, but not limited to future and current impacts of global events such as COVID-19 and the war in the Ukraine, increases in inflation and other risks detailed in our 2021 Annual Report on Form 10K.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not required.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures.

As of March 31, 2022, the Company’s chief executive officer and chief financial officer conducted an evaluation regarding the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act). Based upon the evaluation of these controls and procedures as provided under the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013), our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were ineffective as of the end of the period covered by this report. Management has identified corrective actions for the weakness and will periodically reevaluate the need to add personnel and implement improved review procedures as they can be supported by the growth in our business.

Changes in internal controls.

During the quarterly period covered by this report, no changes occurred in our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1. Description of Business, subheading Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021, which could materially affect our business, financial condition or future results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Note Applicable.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS.

(a) The following documents are filed as exhibits to this report on Form 10-Q or incorporated by reference herein. Any document incorporated by reference is identified by a parenthetical reference to the SEC filing that included such document.

Exhibit No.		Description

3.1		Articles of Incorporation (incorporated herein by reference to Exhibit B to the Information Statement on Form 14-C filed June 21, 2021)

3.2		By-Laws ((incorporated herein by reference to Exhibit C to the Information Statement on Form 14-C filed June 21, 2021).

4.1		Certificate of Designation authorizing issuance of Series A Preferred Stock (incorporated herein by reference to Exhibit D to the Information Statement on Form 14-C filed June 21, 2021)

4.2		Certificate of Designation authorizing the issuance of the Series A-2 Preferred Stock (incorporated herein by reference to Exhibit 3.1 to the Report on Form 8-K filed December 30, 2021)

31		Certification of CEO and CFO pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32		Certification of CEO and CFO pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

QHSLab, Inc.

By:	/s/ Troy Grogan
	Troy Grogan
	Chief Executive Officer and Chief Financial Officer

Date:	May 16, 2022

EX-31 2 ex31.htm

Exhibit 31

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a) UNDER THE EXCHANGE ACT

I, Troy Grogan, certify that:

1. I have reviewed this quarterly report of QHSLab, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;

4. The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as 4efined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the issuer’s most recent fiscal quarter (the issuer’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting; and

5. The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

Date: May 16, 2022

/s/ Troy Grogan
CEO and CFO

EX-32 3 ex32.htm

Exhibit 32

(18 U.S.C. SECTION 1350)

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of QHSLab, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2022 (the “Report”), as filed with the Securities and Exchange Commission (the “Report”), Troy Grogan, Chief Executive Officer and Chief Financial Officer of the Company, does hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Troy Grogan
Troy Grogan
CEO and CFO

Dated: May 16, 2022

A signed original of this written statement required by Section 906 has been provided to QHSLab, Inc. and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.SCH 4 usaq-20220331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - The Company link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Capitalized Software and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Loans Payable link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Preferred Stock link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Loss Per Common Share link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Basis of Presentation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Capitalized Software and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Convertible Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Loss Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Schedule of Indefinite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Schedule of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Capitalized Software and Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Loans Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Schedule of Convertible Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Convertible Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Preferred Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Schedule of Stock-based Compensation Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Schedule of Fair Value of Option Grant of Weighted-average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Options Outstanding and Exercisable (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Schedule of Warrants Outstanding and Exercisable (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Stock-based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 usaq-20220331_cal.xml XBRL CALCULATION FILE EX-101.DEF 6 usaq-20220331_def.xml XBRL DEFINITION FILE EX-101.LAB 7 usaq-20220331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Series A-2 Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Unearned Stock Compensation [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Antidilutive Securities [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Patents [Member] Indefinite-Lived Intangible Assets [Axis] Web Domain [Member] Trademarks [Member] Computer Software, Intangible Asset [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Purchase Agreement [Member] Credit Facility [Axis] Merchant Bank [Member] Short-Term Debt, Type [Axis] Convertible Notes Payable One [Member] Related Party [Axis] Accredited Investor [Member] Convertible Notes Payable Two [Member] Shareholder [Member] Convertible Notes Payable Three [Member] Legal Entity [Axis] Mercer Street Global Opportunity Fund LLC [Member] Long-Term Debt, Type [Axis] Convertible Promissory Note Ten [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Series A2 Convertible Preferred Shares [Member] Stock Options [Member] Stock Warrant [Member] Title of Individual [Axis] Scientific Advisors [Member] Income Statement Location [Axis] Research and Development Expense [Member] Selling and Marketing Expense [Member] General and Administrative Expense [Member] Award Type [Axis] Option One [Member] Option Two [Member] Option Three [Member] Options Held [Member] Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Warrant Four [Member] Warrant Five [Member] Warrant [Member] Factoring Agreement [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] Assets Current Assets: Cash and cash equivalents Accounts receivable Inventory Prepaid expenses and other current assets Total current assets Non-current assets: Capitalized software development costs Intangible assets, net Total assets Liabilities and Stockholders’ Equity Current Liabilities: Accounts payable Other current liabilities Loans payable, current portion Convertible notes payable, current portion Total current liabilities Non-current liabilities: Accrued interest expenses Loans payable, non-current portion Convertible notes payable, non-current portion Total non-current liabilities Total liabilities Commitment and contingencies (Note 12) Stockholders’ Equity: Preferred stock Common stock, 900,000,000 shares authorized, $0.0001 par value; 8,815,508 and 8,756,093 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively Unearned stock compensation Additional paid-in capital Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares authorized Common stock, par value Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of revenue Gross profit Operating Expenses: Sales and marketing General and administrative Research and development Amortization Total Operating Expenses Net operating loss Interest expense Loss on extinguishment of debt Net loss Basic and diluted net loss per share Weighted average shares outstanding (basic and diluted) Beginning balance, value Beginning balance, shares Shares issued for services Conversion of notes payable Conversion of notes payable, shares Warrants issued with conversion of notes payable Stock-based compensation expense Net loss Shares issued for services, shares Cancellation of shares Cancellation of shares, shares Amortization of unearned compensation Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Operating activities Adjustments to reconcile net loss to net cash from operating activities: Amortization of debt and warrant issuance costs Stock-based compensation Shares issued for services Changes in operating assets and liabilities: EX-101.PRE 8 usaq-20220331_pre.xml XBRL PRESENTATION FILE XML 9 R1.htm IDEA: XBRL DOCUMENT

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2022	May 13, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	000-19041
Entity Registrant Name	QHSLab, Inc.
Entity Central Index Key	0000856984
Entity Tax Identification Number	30-1104301
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	901 Northpoint Parkway
Entity Address, Address Line Two	Suite 302
Entity Address, Address Line Three	West Palm
Entity Address, City or Town	Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33407
City Area Code	(929)
Local Phone Number	379-6503
Title of 12(b) Security	Common Stock, $0.0001 Par Value
Trading Symbol	USAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		8,815,508

XML 10 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 155,557	$ 286,855
Accounts receivable	96,093	70,474
Inventory	73,153	65,740
Prepaid expenses and other current assets	71,888	22,713
Total current assets	396,691	445,782
Non-current assets:
Capitalized software development costs	223,390	186,271
Intangible assets, net	1,558,416	1,576,444
Total assets	2,178,497	2,208,497
Current Liabilities:
Accounts payable	33,045	20,370
Other current liabilities	46,328	58,615
Loans payable, current portion	342,239	253,865
Convertible notes payable, current portion	613,954	542,104
Total current liabilities	1,035,566	874,954
Non-current liabilities:
Accrued interest expenses	8,986	6,521
Loans payable, non-current portion	357,834	402,956
Convertible notes payable, non-current portion	100,000	100,000
Total non-current liabilities	466,820	509,477
Total liabilities	1,502,386	1,384,431
Stockholders’ Equity:
Common stock, 900,000,000 shares authorized, $0.0001 par value; 8,815,508 and 8,756,093 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	882	876
Unearned stock compensation	(3,484)	(6,968)
Additional paid-in capital	3,387,540	3,348,681
Accumulated deficit	(2,709,199)	(2,518,895)
Total stockholders’ equity	676,111	824,066
Total liabilities and stockholders’ equity	2,178,497	2,208,497
Series A Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock	108	108
Series A-2 Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock	$ 264	$ 264

XML 11 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Common stock, shares authorized	900,000,000	900,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares issued	8,815,508	8,756,093
Common stock, shares outstanding	8,815,508	8,756,093
Series A Preferred Stock [Member]
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	1,080,092	1,080,092
Preferred stock, shares outstanding	1,080,092	1,080,092
Series A-2 Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares issued	2,644,424	2,644,424
Preferred stock, shares outstanding	2,644,424	2,644,424

XML 12 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenue	$ 355,330	$ 304,336
Cost of revenue	166,642	170,757
Gross profit	188,688	133,579
Operating Expenses:
Sales and marketing	113,294	111,688
General and administrative	89,514	70,127
Research and development	28,979	28,021
Amortization	18,028
Total Operating Expenses	249,815	209,836
Net operating loss	(61,127)	(76,257)
Interest expense	127,157	10,429
Loss on extinguishment of debt	2,020
Net loss	$ (190,304)	$ (86,686)
Basic and diluted net loss per share	$ (0.02)	$ (0.01)
Weighted average shares outstanding (basic and diluted)	8,779,859	6,833,261

XML 13 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series A-2 Preferred Stock [Member]	Common Stock [Member]	Unearned Stock Compensation [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 108		$ 656	$ (124,479)	$ 1,264,108	$ (1,748,719)	$ (608,326)
Beginning balance, shares at Dec. 31, 2020	1,080,092		6,562,735
Shares issued for services			$ 15	(89,419)	89,985		581
Conversion of notes payable			$ 50		194,161		194,211
Conversion of notes payable, shares			496,718
Stock-based compensation expense					8,920		8,920
Net loss						(86,686)	(86,686)
Shares issued for services, shares			150,000
Cancellation of shares			$ (10)		10
Cancellation of shares, shares			(100,000)
Amortization of unearned compensation				67,812			67,812
Ending balance, value at Mar. 31, 2021	$ 108		$ 711	(146,086)	1,557,184	(1,835,405)	(423,488)
Ending balance, shares at Mar. 31, 2021	1,080,092		7,109,453
Beginning balance, value at Dec. 31, 2021	$ 108	$ 264	$ 876	(6,968)	3,348,681	(2,518,895)	824,066
Beginning balance, shares at Dec. 31, 2021	1,080,092	2,644,424	8,756,093
Shares issued for services				3,484			3,484
Conversion of notes payable			$ 6		27,919		27,925
Conversion of notes payable, shares			59,415
Warrants issued with conversion of notes payable					2,020		2,020
Stock-based compensation expense					8,920		8,920
Net loss						(190,304)	(190,304)
Ending balance, value at Mar. 31, 2022	$ 108	$ 264	$ 882	$ (3,484)	$ 3,387,540	$ (2,709,199)	$ 676,111
Ending balance, shares at Mar. 31, 2022	1,080,092	2,644,424	8,815,508

XML 14 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities
Net loss	$ (190,304)	$ (86,686)
Adjustments to reconcile net loss to net cash from operating activities:
Amortization	18,028
Amortization of debt and warrant issuance costs	96,850
Stock-based compensation	8,920	8,920
Shares issued for services	3,484	68,393
Loss on extinguishment of debt	2,020
Changes in operating assets and liabilities:
Increase in accounts receivable	(25,619)	(9,975)
(Increase)/decrease in inventory	(7,413)	38,561
Increase in prepaid expenses and other current assets	(49,175)	(1,088)
Increase/(decrease) in accounts payable	12,675	(67,556)
Decrease in other current liabilities	(14,257)	(433)
Increase in accrued interest	7,360	16,972
Cash flows from operating activities	(137,431)	(32,892)
Investing activities:
Capitalized software	(37,119)	(26,882)
Cash flows from investing activities	(37,119)	(26,882)
Financing activities:
Proceeds of loan borrowings	128,500
Repayments of loan borrowings	(85,248)
Cash flows from financing activities	43,252
Change in cash	(131,298)	(59,774)
Cash and cash equivalents – beginning of year	286,855	94,342
Cash and cash equivalents - end of period	155,557	34,568
Supplemental disclosures of cash flow activity:
Cash paid for interest	18,519	21
Cash paid for taxes
Supplemental noncash investing and financing activity:
Debt and accrued interest converted to shares of common stock	$ 27,925	$ 194,211

XML 15 R7.htm IDEA: XBRL DOCUMENT

The Company

3 Months Ended

Mar. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

The Company

Note 1. The Company

XML 16 R8.htm IDEA: XBRL DOCUMENT

Going Concern

3 Months Ended

Mar. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern

Note 2. Going Concern

XML 17 R9.htm IDEA: XBRL DOCUMENT

Basis of Presentation

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Basis of Presentation

Note 3. Basis of Presentation

Reclassifications

Certain reclassifications were made to the prior condensed consolidated financial statements to conform to the current period presentation. There was no change to the previously reported net loss.

Risks Related to COVID-19 Pandemic

Accounting Policies

U.S. Method Patent	13.4 years

Web Domain	Indefinite life

Trademark	Indefinite life

The estimated useful lives and carrying value of the assets are reviewed at least annually or whenever events or circumstances may result in an impact to the value of the assets.

To determine the revenue to be recognized for transactions that the Company determines are within the scope of ASC 606, the Company follows the established five-step framework as follows:

	(i)	identify the contract(s) with a customer;
	(ii)	identify the performance obligations in the contract(s);
	(iii)	determine the transaction price;
	(iv)	allocate the transaction price to the performance obligations in the contract(s); and
	(v)	recognize revenue when (or as) the Company satisfies a performance obligation.

The Company includes shipping and handling fees billed to customers in revenue.

Recently Issued Accounting Standards

XML 18 R10.htm IDEA: XBRL DOCUMENT

Capitalized Software and Intangible Assets

3 Months Ended

Mar. 31, 2022

Research and Development [Abstract]

Capitalized Software and Intangible Assets

Note 4. Capitalized Software and Intangible Assets

Non-current assets consist of the following at March 31, 2022 and December 31, 2021:

Schedule of Intangible Assets

	Estimated Useful Life (in years)		March 31, 2022			December 31, 2021
Capitalized Software		TBD	$	223,390		$	186,271
Intangible Assets:
U.S. Method Patent		13.4	$	967,500		$	967,500
Web Domain		N/A		161,250			161,250
Trademark		N/A		483,750			483,750
Total Intangible Assets			$	1,612,500		$	1,612,500
Accumulated amortization				(54,084	)		(36,056	)
Intangible assets, net			$	1,558,416		$	1,576,444

XML 19 R11.htm IDEA: XBRL DOCUMENT

Loans Payable

3 Months Ended

Mar. 31, 2022

Loans Payable

Loans Payable

Note 5. Loans Payable

XML 20 R12.htm IDEA: XBRL DOCUMENT

Convertible Notes Payable

3 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Convertible Notes Payable

Note 6. Convertible Notes Payable

Convertible notes payable at March 31, 2022 and December 31, 2021, consist of the following:

Schedule of Convertible Notes Payable

	March 31, 2022			December 31, 2021
Note 1 – Accredited investors	$	-		$	25,000
Note 2 – Shareholder		100,000			100,000
Note 3 – Mercer Note		756,000			756,000
Total		856,000			881,000
Debt discount and issuance costs		(142,046	)		(238,896	)
Total convertible notes payable		713,954			642,104
Less: current portion		613,954			542,104
Non-current portion	$	100,000		$	100,000

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

XML 21 R13.htm IDEA: XBRL DOCUMENT

Preferred Stock

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Preferred Stock

Note 7. Preferred Stock

Series A Preferred Stock

Series A-2 Preferred Stock

XML 22 R14.htm IDEA: XBRL DOCUMENT

Loss Per Common Share

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Loss Per Common Share

Note 8. Loss Per Common Share

	2022		2021
	Three Months Ended March 31,
	2022		2021
Stock options		1,100,000		650,000
Stock warrants		1,026,647		-
Total shares excluded from calculation		2,126,647		650,000

XML 23 R15.htm IDEA: XBRL DOCUMENT

Stock-based Compensation

3 Months Ended

Mar. 31, 2022

Share-Based Payment Arrangement [Abstract]

Stock-based Compensation

Note 9. Stock-based Compensation

	2022		2021
	Three Months Ended March 31,
	2022		2021
Research and development	$	-	$	21,625
Sales and marketing		-		29,187
General and administrative		3,484		17,581
Total expense – shares issued for services	$	3,484	$	68,393

The fair value of all options granted is determined using the Black-Scholes option-pricing model. The following weighted-average assumptions were used:

	Three Months Ended March 31, 2022		Three Months Ended March 31, 2021
Risk-free interest rate		N/A		0.21	%
Expected life of the options		N/A		3.5 years
Expected volatility of the underlying stock		N/A		76.3	%
Expected dividend rate		N/A		0	%

Options outstanding at March 31, 2022 consist of:

Date Issued	Number Outstanding		Number Exercisable		Exercise Price		Expiration Date
March 12, 2020		500,000		333,333	$	0.40	March 12, 2025
June 27, 2020		150,000		100,000	$	0.40	June 27, 2025
January 1, 2021		450,000		150,000	$	0.65	December 31, 2025
Total		1,100,000		583,333

Warrants outstanding at March 31, 2022 consist of:

Date Issued	Number Outstanding		Number Exercisable		Exercise Price		Expiration Date
March 16, 2021		15,900		15,900	$	0.75	March 15, 2023
May 7, 2021		53,704		53,704	$	0.74	May 6, 2023
June 17, 2021		12,189		12,189	$	0.83	June 16, 2023
August 10, 2021		930,000		930,000	$	1.25	August 9, 2024
February 23, 2022		14,854		14,854	$	0.705	February 22, 2024
Total		1,026,647		1,026,647

XML 24 R16.htm IDEA: XBRL DOCUMENT

Related Party Transactions

3 Months Ended

Mar. 31, 2022

Related Party Transactions

Note 10. Related Party Transactions

Convertible notes payable, related party: See Note 6.

XML 25 R17.htm IDEA: XBRL DOCUMENT

Income Taxes

3 Months Ended

Mar. 31, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Note 11. Income Taxes

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 26 R18.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 12. Commitments and Contingencies

There are no pending or threatened legal proceedings as of March 31, 2022. The Company has no non-cancellable operating leases.

XML 27 R19.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Use of Estimates

Principles of Consolidation

Cash and Cash Equivalents

Accounts Receivable

Inventories

Capitalized Software Development Costs

U.S. Method Patent	13.4 years

Web Domain	Indefinite life

Trademark	Indefinite life

The estimated useful lives and carrying value of the assets are reviewed at least annually or whenever events or circumstances may result in an impact to the value of the assets.

Revenue Recognition

To determine the revenue to be recognized for transactions that the Company determines are within the scope of ASC 606, the Company follows the established five-step framework as follows:

	(i)	identify the contract(s) with a customer;
	(ii)	identify the performance obligations in the contract(s);
	(iii)	determine the transaction price;
	(iv)	allocate the transaction price to the performance obligations in the contract(s); and
	(v)	recognize revenue when (or as) the Company satisfies a performance obligation.

The Company includes shipping and handling fees billed to customers in revenue.

Research and Development

Stock-based Compensation

Earnings Per Common Share

Income Taxes

Recently Issued Accounting Standards

Recently Issued Accounting Standards

XML 28 R20.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Schedule of Indefinite-Lived Intangible Assets

U.S. Method Patent	13.4 years

Web Domain	Indefinite life

Trademark	Indefinite life

XML 29 R21.htm IDEA: XBRL DOCUMENT

Capitalized Software and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2022

Research and Development [Abstract]

Schedule of Intangible Assets

Non-current assets consist of the following at March 31, 2022 and December 31, 2021:

Schedule of Intangible Assets

	Estimated Useful Life (in years)		March 31, 2022			December 31, 2021
Capitalized Software		TBD	$	223,390		$	186,271
Intangible Assets:
U.S. Method Patent		13.4	$	967,500		$	967,500
Web Domain		N/A		161,250			161,250
Trademark		N/A		483,750			483,750
Total Intangible Assets			$	1,612,500		$	1,612,500
Accumulated amortization				(54,084	)		(36,056	)
Intangible assets, net			$	1,558,416		$	1,576,444

XML 30 R22.htm IDEA: XBRL DOCUMENT

Convertible Notes Payable (Tables)

3 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Schedule of Convertible Notes Payable

Convertible notes payable at March 31, 2022 and December 31, 2021, consist of the following:

Schedule of Convertible Notes Payable

	March 31, 2022			December 31, 2021
Note 1 – Accredited investors	$	-		$	25,000
Note 2 – Shareholder		100,000			100,000
Note 3 – Mercer Note		756,000			756,000
Total		856,000			881,000
Debt discount and issuance costs		(142,046	)		(238,896	)
Total convertible notes payable		713,954			642,104
Less: current portion		613,954			542,104
Non-current portion	$	100,000		$	100,000

XML 31 R23.htm IDEA: XBRL DOCUMENT

Loss Per Common Share (Tables)

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share

	2022		2021
	Three Months Ended March 31,
	2022		2021
Stock options		1,100,000		650,000
Stock warrants		1,026,647		-
Total shares excluded from calculation		2,126,647		650,000

XML 32 R24.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expenses

	2022		2021
	Three Months Ended March 31,
	2022		2021
Research and development	$	-	$	21,625
Sales and marketing		-		29,187
General and administrative		3,484		17,581
Total expense – shares issued for services	$	3,484	$	68,393

Schedule of Fair Value of Option Grant of Weighted-average Assumptions

The fair value of all options granted is determined using the Black-Scholes option-pricing model. The following weighted-average assumptions were used:

	Three Months Ended March 31, 2022		Three Months Ended March 31, 2021
Risk-free interest rate		N/A		0.21	%
Expected life of the options		N/A		3.5 years
Expected volatility of the underlying stock		N/A		76.3	%
Expected dividend rate		N/A		0	%

Schedule of Options Outstanding and Exercisable

Options outstanding at March 31, 2022 consist of:

Date Issued	Number Outstanding		Number Exercisable		Exercise Price		Expiration Date
March 12, 2020		500,000		333,333	$	0.40	March 12, 2025
June 27, 2020		150,000		100,000	$	0.40	June 27, 2025
January 1, 2021		450,000		150,000	$	0.65	December 31, 2025
Total		1,100,000		583,333

Schedule of Warrants Outstanding and Exercisable

Warrants outstanding at March 31, 2022 consist of:

Date Issued	Number Outstanding		Number Exercisable		Exercise Price		Expiration Date
March 16, 2021		15,900		15,900	$	0.75	March 15, 2023
May 7, 2021		53,704		53,704	$	0.74	May 6, 2023
June 17, 2021		12,189		12,189	$	0.83	June 16, 2023
August 10, 2021		930,000		930,000	$	1.25	August 9, 2024
February 23, 2022		14,854		14,854	$	0.705	February 22, 2024
Total		1,026,647		1,026,647

XML 33 R25.htm IDEA: XBRL DOCUMENT

Schedule of Indefinite-Lived Intangible Assets (Details)	3 Months Ended
	Mar. 31, 2022
Web Domain [Member]
Finite-Lived Intangible Assets [Line Items]
Impaired intangible asset	Indefinite life
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Impaired intangible asset	Indefinite life
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, amortization method	13 years 4 months 24 days

XML 34 R26.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
Basis of Presentation (Details Narrative) - USD ($)	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Capitalized software development costs for software sold to customers	$ 223,390		$ 186,271
Capitalized computer software, amortization	0		0
Capitalized computer software, impairments	0		$ 0
Research and development expense	$ 28,979	$ 28,021
Common stock equivalent shares of weighted average shares outstanding dilutive	2,126,647	650,000
Operating loss carryforwards	$ 2,709,199
Net operating losses carryforwards, expire date	begin to expire in 2027
Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock equivalent shares of weighted average shares outstanding dilutive	0		0

XML 35 R27.htm IDEA: XBRL DOCUMENT

Schedule of Intangible Assets (Details) - USD ($)	3 Months Ended
Schedule of Intangible Assets (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Total Intangible Assets	$ 1,612,500	$ 1,612,500
Intangible Assets:
Accumulated amortization	(54,084)	(36,056)
Intangible assets, net	1,558,416	1,576,444
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Total Intangible Assets	223,390	186,271
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Total Intangible Assets	$ 967,500	967,500
Intangible Assets:
Finite-lived intangible assets, amortization method	13 years 4 months 24 days
Web Domain [Member]
Finite-Lived Intangible Assets [Line Items]
Total Intangible Assets	$ 161,250	161,250
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Total Intangible Assets	$ 483,750	$ 483,750

XML 36 R28.htm IDEA: XBRL DOCUMENT

Capitalized Software and Intangible Assets (Details Narrative) - USD ($)		3 Months Ended		12 Months Ended
	Jun. 23, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Research and Development [Abstract]
Capitalized computer software, impairments		$ 0		$ 0
Acquired intangible assets	$ 1,612,500
Amortization expense		$ 18,028

XML 37 R29.htm IDEA: XBRL DOCUMENT

Loans Payable (Details Narrative) - USD ($)	Mar. 02, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 23, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt default longterm debt amount		$ 586,716	$ 644,158
Proceeds from Issuance of Debt	$ 128,500
Payments for loan	$ 16,305
Loan payable		$ 117,117
Merchant Bank [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Loan payable			$ 16,793
Purchase Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt instrument face amount				$ 750,000

XML 38 R30.htm IDEA: XBRL DOCUMENT

Schedule of Convertible Notes Payable (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Total	$ 856,000	$ 881,000
Debt discount and issuance costs	(142,046)	(238,896)
Total convertible notes payable	713,954	642,104
Less: current portion	613,954	542,104
Non-current portion	100,000	100,000
Convertible Notes Payable One [Member] \| Accredited Investor [Member]
Short-Term Debt [Line Items]
Total		25,000
Convertible Notes Payable Two [Member] \| Shareholder [Member]
Short-Term Debt [Line Items]
Total	100,000	100,000
Convertible Notes Payable Three [Member] \| Mercer Street Global Opportunity Fund LLC [Member]
Short-Term Debt [Line Items]
Total	$ 756,000	$ 756,000

XML 39 R31.htm IDEA: XBRL DOCUMENT

Convertible Notes Payable (Details Narrative) - USD ($)					3 Months Ended
Convertible Notes Payable (Details Narrative) - USD ($)	Nov. 11, 2021	Aug. 10, 2021	May 07, 2021	Dec. 23, 2020	Mar. 31, 2022	Mar. 31, 2021	Aug. 10, 2022	Feb. 23, 2022	Dec. 31, 2021	Nov. 15, 2021	Sep. 21, 2021
Short-Term Debt [Line Items]
Interest Payable, Current					$ 24,767				$ 15,446
Stock Issued During Period, Value, Conversion of Convertible Securities					27,925	$ 194,211
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net					121,794				204,835
Debt Instrument, Unamortized Discount					20,252				34,060
Convertible Promissory Note Ten [Member]
Short-Term Debt [Line Items]
Debt instrument convertible conversion price1										$ 0.65	$ 0.65
Convertible Promissory Note Ten [Member] \| Subsequent Event [Member]
Short-Term Debt [Line Items]
Debt instrument convertible conversion price1							$ 0.65
Debt instrument interest rate stated percentage							5.00%
Mercer Street Global Opportunity Fund LLC [Member]
Short-Term Debt [Line Items]
Debt instrument, principal amount	$ 806,000
Debt instrument convertible conversion price1	$ 0.65
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	930,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.25
Stock Issued During Period, Value, Conversion of Convertible Securities	$ 50,000
Stock Issued During Period, Shares, Conversion of Convertible Securities	76,923
Convertible Notes Payable One [Member] \| Accredited Investor [Member]
Short-Term Debt [Line Items]
Debt instrument, principal amount				$ 25,000				$ 25,000
Debt Instrument, Maturity Date				Sep. 25, 2020
Interest Payable, Current					0			$ 59,415	2,555
Debt instrument convertible conversion price1								$ 0.47
Class of Warrant or Right, Number of Securities Called by Warrants or Rights								14,854
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 0.705
Convertible Notes Payable Two [Member] \| Shareholder [Member]
Short-Term Debt [Line Items]
Debt instrument, principal amount			$ 100,000
Debt Instrument, Maturity Date			Sep. 30, 2022
Interest Payable, Current					$ 8,986				$ 6,521
Debt instrument interest rate stated percentage			10.00%
Debt Instrument, Description			The Company may satisfy the Note upon maturity or Default, as defined, by the issuance of common shares at a conversion price equal to the greater of a 25% discount to the 15-day average market price of the Company’s common stock or $0.50. The principal and interest accrued are convertible at any time through the maturity date of September 30, 2022 at the option of the holder using the same conversion calculation
Convertible Notes Payable Three [Member] \| Mercer Street Global Opportunity Fund LLC [Member]
Short-Term Debt [Line Items]
Debt instrument, principal amount		$ 806,000
Warrants to purchase common stock		930,000
Proceeds from Warrant Exercises		$ 750,000

XML 40 R32.htm IDEA: XBRL DOCUMENT

Preferred Stock (Details Narrative) - USD ($)	Dec. 30, 2021	Sep. 01, 2019	Mar. 31, 2022	Dec. 31, 2021
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock stated value		$ 0.25	$ 0.0001	$ 0.0001
Debt instrument, conversion price		$ 0.05
Preferred stock voting rights description		The Series A Preferred Stock does not accrue dividends and ranks prior to the common stock upon a liquidation of the Company. The Series A Preferred Stock votes on all matters brought before the shareholders together with the Common stock as a single class and each share of Series A Preferred Stock has a number of votes, initially 5, equal to the number of shares of preferred stock into which it is convertible as of the record date for any vote.
Series A2 Convertible Preferred Shares [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, New Issues	$ 2,644,424
Debt Instrument, Face Amount	$ 286,078

XML 41 R33.htm IDEA: XBRL DOCUMENT

Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	2,126,647	650,000
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	1,100,000	650,000
Stock Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	1,026,647

XML 42 R34.htm IDEA: XBRL DOCUMENT

Schedule of Stock-based Compensation Expenses (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense – shares issued for services	$ 3,484	$ 68,393
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense – shares issued for services		21,625
Selling and Marketing Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense – shares issued for services		29,187
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense – shares issued for services	$ 3,484	$ 17,581

XML 43 R35.htm IDEA: XBRL DOCUMENT

Schedule of Fair Value of Option Grant of Weighted-average Assumptions (Details)	3 Months Ended
	Mar. 31, 2021
Share-Based Payment Arrangement [Abstract]
Risk-free interest rate	0.21%
Expected life of the options	3 years 6 months
Expected volatility of the underlying stock	76.30%
Expected dividend rate	0.00%

XML 44 R36.htm IDEA: XBRL DOCUMENT

Schedule of Options Outstanding and Exercisable (Details)	3 Months Ended
	Mar. 31, 2022 $ / shares shares
Option One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Date Issued	Mar. 12, 2020
Number Outstanding	500,000
Number Exercisable	333,333
Exercise Price \| $ / shares	$ 0.40
Expiration Date	Mar. 12, 2025
Option Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Date Issued	Jun. 27, 2020
Number Outstanding	150,000
Number Exercisable	100,000
Exercise Price \| $ / shares	$ 0.40
Expiration Date	Jun. 27, 2025
Option Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Date Issued	Jan. 01, 2021
Number Outstanding	450,000
Number Exercisable	150,000
Exercise Price \| $ / shares	$ 0.65
Expiration Date	Dec. 31, 2025
Options Held [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number Outstanding	1,100,000
Number Exercisable	583,333

XML 45 R37.htm IDEA: XBRL DOCUMENT

Schedule of Warrants Outstanding and Exercisable (Details)	3 Months Ended
	Mar. 31, 2022 $ / shares shares
Warrant One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Date Issued	Mar. 16, 2021
Number Outstanding	15,900
Number Exercisable	15,900
Exercise Price \| $ / shares	$ 0.75
Expiration Date	Mar. 15, 2023
Warrant Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Date Issued	May 07, 2021
Number Outstanding	53,704
Number Exercisable	53,704
Exercise Price \| $ / shares	$ 0.74
Expiration Date	May 06, 2023
Warrant Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Date Issued	Jun. 17, 2021
Number Outstanding	12,189
Number Exercisable	12,189
Exercise Price \| $ / shares	$ 0.83
Expiration Date	Jun. 16, 2023
Warrant Four [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Date Issued	Aug. 10, 2021
Number Outstanding	930,000
Number Exercisable	930,000
Exercise Price \| $ / shares	$ 1.25
Expiration Date	Aug. 09, 2024
Warrant Five [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Date Issued	Feb. 23, 2022
Number Outstanding	14,854
Number Exercisable	14,854
Exercise Price \| $ / shares	$ 0.705
Expiration Date	Feb. 22, 2024
Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number Outstanding	1,026,647
Number Exercisable	1,026,647

XML 46 R38.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Details Narrative) - USD ($)	3 Months Ended
Stock-based Compensation (Details Narrative) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Share-Based Payment Arrangement, Noncash Expense	$ 8,920	$ 8,920
Unrecognized compensation related to unvested options	$ 27,164
Unrecognized compensation related to unvested options, shares	1,100,000
Recognized weighted-average period	11 months
Weighted-average fair value for options granted		$ 0.12
Scientific Advisors [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Number of options granted		450,000
Weighted-average exercise price		$ 0.65
Options vesting term		3 years
Options expiration period		5 years

XML 47 R39.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative) - USD ($)	Feb. 09, 2021	Mar. 31, 2022	Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Other current liabilities		$ 46,328	$ 58,615
Factoring Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Agreement term	1 year
Advances on sale on receivables	$ 150,000
Reserve of purchased receivables, percentage	10.00%
Factoring fees, percentage	1.80%
Other current liabilities		$ 10,334	$ 25,420

XML 48 form10-q_htm.xml IDEA: XBRL DOCUMENT 0000856984 2022-01-01 2022-03-31 0000856984 2022-05-13 0000856984 2022-03-31 0000856984 2021-12-31 0000856984 us-gaap:SeriesAPreferredStockMember 2022-03-31 0000856984 us-gaap:SeriesAPreferredStockMember 2021-12-31 0000856984 USAQ:SeriesATwoPreferredStockMember 2022-03-31 0000856984 USAQ:SeriesATwoPreferredStockMember 2021-12-31 0000856984 2021-01-01 2021-03-31 0000856984 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0000856984 USAQ:SeriesATwoPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0000856984 us-gaap:CommonStockMember 2021-12-31 0000856984 USAQ:UnearnedStockCompensationMember 2021-12-31 0000856984 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000856984 us-gaap:RetainedEarningsMember 2021-12-31 0000856984 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0000856984 USAQ:SeriesATwoPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0000856984 us-gaap:CommonStockMember 2020-12-31 0000856984 USAQ:UnearnedStockCompensationMember 2020-12-31 0000856984 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000856984 us-gaap:RetainedEarningsMember 2020-12-31 0000856984 2020-12-31 0000856984 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0000856984 USAQ:SeriesATwoPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0000856984 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000856984 USAQ:UnearnedStockCompensationMember 2022-01-01 2022-03-31 0000856984 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000856984 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000856984 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000856984 USAQ:SeriesATwoPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000856984 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000856984 USAQ:UnearnedStockCompensationMember 2021-01-01 2021-03-31 0000856984 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000856984 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000856984 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0000856984 USAQ:SeriesATwoPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0000856984 us-gaap:CommonStockMember 2022-03-31 0000856984 USAQ:UnearnedStockCompensationMember 2022-03-31 0000856984 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000856984 us-gaap:RetainedEarningsMember 2022-03-31 0000856984 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0000856984 USAQ:SeriesATwoPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0000856984 us-gaap:CommonStockMember 2021-03-31 0000856984 USAQ:UnearnedStockCompensationMember 2021-03-31 0000856984 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000856984 us-gaap:RetainedEarningsMember 2021-03-31 0000856984 2021-03-31 0000856984 2021-01-01 2021-12-31 0000856984 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000856984 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000856984 us-gaap:PatentsMember 2022-01-01 2022-03-31 0000856984 USAQ:WebDomainMember 2022-01-01 2022-03-31 0000856984 us-gaap:TrademarksMember 2022-01-01 2022-03-31 0000856984 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-03-31 0000856984 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-12-31 0000856984 us-gaap:PatentsMember 2022-03-31 0000856984 us-gaap:PatentsMember 2021-12-31 0000856984 USAQ:WebDomainMember 2022-03-31 0000856984 USAQ:WebDomainMember 2021-12-31 0000856984 us-gaap:TrademarksMember 2022-03-31 0000856984 us-gaap:TrademarksMember 2021-12-31 0000856984 2021-06-22 2021-06-23 0000856984 USAQ:PurchaseAgreementMember 2021-06-23 0000856984 2022-03-01 2022-03-02 0000856984 USAQ:MerchantBankMember 2021-12-31 0000856984 USAQ:AccreditedInvestorMember USAQ:ConvertibleNotesPayableOneMember 2022-03-31 0000856984 USAQ:AccreditedInvestorMember USAQ:ConvertibleNotesPayableOneMember 2021-12-31 0000856984 USAQ:ShareholderMember USAQ:ConvertibleNotesPayableTwoMember 2022-03-31 0000856984 USAQ:ShareholderMember USAQ:ConvertibleNotesPayableTwoMember 2021-12-31 0000856984 USAQ:ConvertibleNotesPayableThreeMember USAQ:MercerStreetGlobalOpportunityFundLLCMember 2022-03-31 0000856984 USAQ:ConvertibleNotesPayableThreeMember USAQ:MercerStreetGlobalOpportunityFundLLCMember 2021-12-31 0000856984 USAQ:AccreditedInvestorMember USAQ:ConvertibleNotesPayableOneMember 2020-12-23 0000856984 USAQ:AccreditedInvestorMember USAQ:ConvertibleNotesPayableOneMember 2020-12-22 2020-12-23 0000856984 USAQ:AccreditedInvestorMember USAQ:ConvertibleNotesPayableOneMember 2022-02-23 0000856984 USAQ:ShareholderMember USAQ:ConvertibleNotesPayableTwoMember 2021-05-07 0000856984 USAQ:ShareholderMember USAQ:ConvertibleNotesPayableTwoMember 2021-05-01 2021-05-07 0000856984 USAQ:ConvertibleNotesPayableThreeMember USAQ:MercerStreetGlobalOpportunityFundLLCMember 2021-08-10 0000856984 USAQ:ConvertibleNotesPayableThreeMember USAQ:MercerStreetGlobalOpportunityFundLLCMember 2021-08-01 2021-08-10 0000856984 USAQ:ConvertiblePromissoryNoteTenMember us-gaap:SubsequentEventMember 2022-08-10 0000856984 USAQ:ConvertiblePromissoryNoteTenMember 2021-11-15 0000856984 USAQ:ConvertiblePromissoryNoteTenMember 2021-09-21 0000856984 USAQ:MercerStreetGlobalOpportunityFundLLCMember 2021-11-09 2021-11-11 0000856984 USAQ:MercerStreetGlobalOpportunityFundLLCMember 2021-11-11 0000856984 us-gaap:SeriesAPreferredStockMember 2019-09-01 0000856984 us-gaap:SeriesAPreferredStockMember 2019-08-31 2019-09-01 0000856984 USAQ:SeriesA2ConvertiblePreferredSharesMember 2021-12-29 2021-12-30 0000856984 USAQ:SeriesA2ConvertiblePreferredSharesMember 2021-12-30 0000856984 USAQ:StockOptionsMember 2022-01-01 2022-03-31 0000856984 USAQ:StockOptionsMember 2021-01-01 2021-03-31 0000856984 USAQ:StockWarrantMember 2022-01-01 2022-03-31 0000856984 USAQ:StockWarrantMember 2021-01-01 2021-03-31 0000856984 USAQ:ScientificAdvisorsMember 2021-01-01 2021-03-31 0000856984 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-03-31 0000856984 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-03-31 0000856984 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-03-31 0000856984 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-03-31 0000856984 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-03-31 0000856984 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0000856984 USAQ:OptionOneMember 2022-01-01 2022-03-31 0000856984 USAQ:OptionOneMember 2022-03-31 0000856984 USAQ:OptionTwoMember 2022-01-01 2022-03-31 0000856984 USAQ:OptionTwoMember 2022-03-31 0000856984 USAQ:OptionThreeMember 2022-01-01 2022-03-31 0000856984 USAQ:OptionThreeMember 2022-03-31 0000856984 us-gaap:OptionMember 2022-03-31 0000856984 USAQ:WarrantOneMember 2022-01-01 2022-03-31 0000856984 USAQ:WarrantOneMember 2022-03-31 0000856984 USAQ:WarrantTwoMember 2022-01-01 2022-03-31 0000856984 USAQ:WarrantTwoMember 2022-03-31 0000856984 USAQ:WarrantThreeMember 2022-01-01 2022-03-31 0000856984 USAQ:WarrantThreeMember 2022-03-31 0000856984 USAQ:WarrantFourMember 2022-01-01 2022-03-31 0000856984 USAQ:WarrantFourMember 2022-03-31 0000856984 USAQ:WarrantFiveMember 2022-01-01 2022-03-31 0000856984 USAQ:WarrantFiveMember 2022-03-31 0000856984 us-gaap:WarrantMember 2022-03-31 0000856984 USAQ:FactoringAgreementMember 2021-02-09 2021-02-09 0000856984 USAQ:FactoringAgreementMember 2021-02-09 0000856984 USAQ:FactoringAgreementMember 2022-03-31 0000856984 USAQ:FactoringAgreementMember 2021-12-31 iso4217:USD shares iso4217:USD shares pure 0000856984 false Q1 --12-31

10-Q true 2022-03-31 2022 false 000-19041 QHSLab, Inc. NV 30-1104301 901 Northpoint Parkway Suite 302 West Palm Beach FL 33407 (929) 379-6503 Common Stock, $0.0001 Par Value USAQ Yes Yes Non-accelerated Filer true true false false 8815508

155557

286855

96093

70474

73153

65740

71888

22713

396691

445782

223390

186271

1558416

1576444

2178497

2208497

33045

20370

46328

58615

342239

253865

613954

542104

1035566

874954

8986 6521

357834

402956

100000

466820

509477

1502386

1384431

10000000

0.0001

1080092

108

0.0001

2644424

264

900000000

0.0001

8815508

8756093

882

876

3484

6968

3387540

3348681

-2709199

-2518895

676111

824066

2178497

2208497

355330

304336

166642

170757

188688

133579

113294

111688

89514

70127

28979

28021

18028

249815

209836

-61127

-76257

127157

10429

-2020

-190304

-86686

-0.02

-0.01

8779859

6833261

1080092

108

2644424

264

8756093

876

-6968

3348681

-2518895

824066

3484

59415

27919

27925

2020

8920

-190304

1080092

108

2644424

264

8815508

882

-3484

3387540

-2709199

676111

1080092

108

6562735

656

-124479

1264108

-1748719

-608326

150000

-89419

89985

581

496718

194161

194211

-100000

-10

67812 67812

8920

-86686

1080092

108

7109453

711

-146086

1557184

-1835405

-423488

-190304

-86686

18028

96850

8920

3484

68393

-2020

25619

9975

7413

-38561

49175

1088

12675

-67556

-14257

-433

7360

16972

-137431

-32892

37119

26882

-37119

-26882

128500

85248

43252

-131298

-59774

286855

94342

155557

34568

18519

27925 194211

Note 1. The Company QHSLab, Inc. (f/k/a USA Equities Corp.) (the “Company”, or the “Registrant”) was incorporated in Delaware on September 1, 1983. In 2015, the Company changed its name to USA Equities Corp. On September 23, 2021, the Company changed its state of incorporation from Delaware to Nevada as a result of a merger with and into its newly formed wholly-owned subsidiary, USA Equities Corp., a Nevada corporation (“USA Equities Nevada”), the surviving entity pursuant to an Agreement and Plan of Merger. The reincorporation was approved by the stockholders of the Company and USA Equities Nevada is deemed to be the successor to USA Equities Corp, the Delaware corporation. On April 19, 2022, the Company changed its name to QHSLab, Inc. The Company is a medical device technology and software as a service (“SaaS”) company focused on enabling primary care physicians (“PCP’s”) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.

Note 2. Going Concern The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred losses since inception, has negative operational cash flows and began recognizing revenues in the fourth quarter of fiscal 2020. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The continuation of the Company’s business is dependent upon its ability to achieve profitability and positive cash flows and, pending such achievement, future issuances of equity or other financings to fund ongoing operations. However, access to such funding may not be available on commercially reasonable terms, if at all. These condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note 3. Basis of Presentation The condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring accruals, necessary for a fair statement of financial position, results of operations, and cash flows. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and the accompanying notes included in our Annual Report on Form 10- K for the year ended December 31, 2021. The accounting policies are described in the “Notes to the Consolidated Financial Statements” in the 2021 Annual Report on Form 10-K and updated, as necessary, in this Form 10-Q. The year-end balance sheet data presented for comparative purposes was derived from audited consolidated financial statements but does not include all disclosures required by accounting principles generally accepted in the United States. The results of operations for the three months ended March 31, 2022 and 2021 are not necessarily indicative of the operating results for the full year or for any other subsequent interim period. Reclassifications Certain reclassifications were made to the prior condensed consolidated financial statements to conform to the current period presentation. There was no change to the previously reported net loss. Risks Related to COVID-19 Pandemic The COVID-19 pandemic is affecting the United States and global economies and may affect the Company’s operations and those of third parties on which the Company relies. While the potential economic impact brought by, and the duration of, the COVID-19 pandemic is difficult to assess or predict, the impact of the COVID-19 pandemic could negatively impact the Company’s short-term and long-term liquidity. The ultimate impact of the COVID-19 pandemic is highly uncertain and the Company does not yet know the full extent of potential impacts on its business, financing or global economy as a whole. However, these effects could have a material impact on the Company’s liquidity, capital resources and operations. Accounting Policies Use of Estimates: The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates. Principles of Consolidation: The condensed consolidated financial statements include the accounts of QHSLab, Inc. and its wholly owned subsidiaries USAQ Corporation, Inc., and Medical Practice Income, Inc. All significant inter-company balances and transactions have been eliminated. Cash and Cash Equivalents: For financial statement presentation purposes, the Company considers those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents. Accounts Receivable: The Company extends unsecured credit to its customers on a regular basis. Management monitors the payments on outstanding balances and will establish a reserve for uncollectible balances as necessary based on experience. Inventories: Inventories are stated at the lower of cost or estimated net realizable value, on a first-in, first-out, or FIFO, basis. The Company uses actual costs to determine its cost basis for inventories. Inventories consist of only finished goods. Capitalized Software Development Costs: Software development costs for internal-use software are accounted for in accordance with Accounting Standards Codification (“ASC”) 350-40, Internal-Use Software. Development costs that are incurred during the application development stage begin to be capitalized when two criteria are met: (i) the preliminary project stage is completed and (ii) it is probable that the software will be completed and used for its intended function. Capitalization ceases once the software is substantially complete and ready for its intended use. Costs incurred during the preliminary project stage of software development and post-implementation operating stages are expensed as incurred. Amortization is calculated on a straight-line basis over the remaining economic life of the software (typically three to five years) and will be included in the operating expenses on the condensed consolidated Statements of Operations once amortization begins. The estimated useful lives of software are reviewed at least annually and will be tested for impairment whenever events or changes in circumstances occur that could impact the recoverability of the assets. Capitalized software development costs for internal-use software totaled $223,390 as of March 31, 2022 and $186,271 as of December 31, 2021. The software application is still in development with costs continuing to be capitalized and no amortization expense being recognized during the periods ended March 31, 2022 and December 31, 2021. There were no impairments recognized during the periods ended March 31, 2022 and December 31, 2021. Intangible Assets: Intangible assets represent the value the Company paid to acquire assets including a trademark, patent and web domain on June 23, 2021. The allocation of the purchase price to each of these assets was determined based on ASC 805-50-30, Business Combination, Related Issues, Initial Measurement. These assets are accounted for in accordance with ASC 350-30, Intangibles, General Intangibles Other Than Goodwill. The cost of the assets is amortized over the remaining useful life of the assets as follows: Schedule of Indefinite-Lived Intangible Assets <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20%">U.S. Method Patent</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zHxEmFIOfDP4" title="Finite-lived intangible assets, amortization method">13.4 years</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Web Domain</td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--ImpairedIntangibleAssetDescription_c20220101__20220331__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebDomainMember_z5IXdDHO6vS2" title="Impaired intangible asset">Indefinite life</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Trademark</td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ImpairedIntangibleAssetDescription_c20220101__20220331__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zpq8VzILfMxi" title="Impaired intangible asset">Indefinite life</td></tr> </table> The estimated useful lives and carrying value of the assets are reviewed at least annually or whenever events or circumstances may result in an impact to the value of the assets. Convertible Notes Payable: The Company accounts for convertible notes deemed conventional and conversion options embedded in non-conventional convertible notes which qualify as equity under ASC 815, Derivatives and Hedging, in accordance with the provisions of ASC 470-20, Debt with Conversion and Other Options, which provides guidance on accounting for convertible securities with beneficial conversion features. ASC 470-20 addresses classification determination for specific obligations, such as short-term obligations expected to be refinanced on a long-term basis, due-on-demand loan arrangements, callable debt, sales of future revenue, increasing rate debt, debt that includes covenants, revolving credit agreements subject to lock-box arrangements and subjective acceleration clauses. Accordingly, the Company records, as a discount to convertible notes, the intrinsic value of such conversion options based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt. Revenue Recognition: Pursuant to ASC Topic 606, Revenue from Contracts with Customers, or ASC 606, the Company recognizes revenue upon transfer of control of goods, in an amount that reflects the consideration that is expected to be received in exchange for those goods. The Company does not allow for the return of products and therefore does not establish an allowance for returns. To determine the revenue to be recognized for transactions that the Company determines are within the scope of ASC 606, the Company follows the established five-step framework as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.5in">(i)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">identify the contract(s) with a customer;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(ii)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">identify the performance obligations in the contract(s);</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(iii)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">determine the transaction price;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(iv)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">allocate the transaction price to the performance obligations in the contract(s); and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(v)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">recognize revenue when (or as) the Company satisfies a performance obligation.</td></tr> </table> The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians. Revenue is recognized once the Company satisfies its performance obligation which occurs at the point in time when title and possession of products have transitioned to the customer, typically upon delivery of the products. The Company includes shipping and handling fees billed to customers in revenue. There are several practical expedients and exemptions allowed under ASC 606 that impact timing of revenue recognition and disclosures. The Company elected to treat similar contracts as a portfolio of contracts, as allowed under ASC 606. The contracts that fall within the portfolio have the same terms and management has the expectation that the result will not be materially different from the consideration of each individual contract. Research and Development: Research and development expense is primarily related to developing and improving methods related to the Company’s Software as a Service (SaaS) platform. Research and development expenses are expensed when incurred. For the three months ended March 31, 2022 and 2021, there were $28,979 and $28,021 of research and development expenses incurred, respectively. Stock-based Compensation: The Company applies the fair value method of ASC 718, Share Based Payment, in accounting for its stock-based compensation. The standard states that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values stock-based compensation at the market price for the Company’s common stock and other pertinent factors at the grant date. Earnings Per Common Share: Basic net loss per share is computed using the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed using the weighted average number of common and dilutive equivalent shares outstanding during the period. Dilutive common equivalent shares consist of options and warrants to purchase common stock (only if those options and warrants are exercisable and at prices below the average share price for the period) and shares issuable upon the conversion of issued and outstanding preferred stock. Due to the net losses reported, dilutive common equivalent shares were excluded from the computation of diluted loss per share, as inclusion would be anti-dilutive for the periods presented. There were <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20220101__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zQuBiggEQMJ7" title="Common stock equivalent shares of weighted average shares outstanding dilutive"><span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zurDzV0gsLe7" title="Common stock equivalent shares of weighted average shares outstanding dilutive">no common equivalent shares required to be added to the basic weighted average shares outstanding to arrive at diluted weighted average shares outstanding as of March 31, 2022 or 2021. Income Taxes: The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized. The Company has net operating losses of $2,709,199 which begin to expire in 2027. Future utilization of currently generated federal and state NOL and tax credit carry forwards may be subject to a substantial annual limitation due to the ownership change limitations. The annual limitation may result in the expiration of NOL and tax credit carry-forwards before full utilization. Recently Issued Accounting Standards In August 2020, the Financial Accounts Standards Board (“FASB”) issued Accounting Standards Updates (“ASU”) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40), or ASU 2020-06. The updated guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. Consequently, more convertible debt instruments will be reported as single liability instruments with no separate accounting for embedded conversion features. The ASU 2020-06 also removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. In addition, ASU 2020-06 also simplifies the diluted net income per share calculation in certain areas. The Company adopted the provisions of ASU 2020-06 using a modified retrospective approach, which resulted in no cumulative effect adjustment to stockholders’ deficit as of January 1, 2021. This Quarterly Report on Form 10-Q does not discuss recent pronouncements that are not anticipated to have a current and/or future impact on or are unrelated to the Company’s financial condition, results of operations, cash flows or disclosures.

Use of Estimates: The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.

Principles of Consolidation: The condensed consolidated financial statements include the accounts of QHSLab, Inc. and its wholly owned subsidiaries USAQ Corporation, Inc., and Medical Practice Income, Inc. All significant inter-company balances and transactions have been eliminated.

Cash and Cash Equivalents: For financial statement presentation purposes, the Company considers those short-term, highly liquid investments with original maturities of three months or less to be cash or cash equivalents.

Accounts Receivable: The Company extends unsecured credit to its customers on a regular basis. Management monitors the payments on outstanding balances and will establish a reserve for uncollectible balances as necessary based on experience.

Inventories: Inventories are stated at the lower of cost or estimated net realizable value, on a first-in, first-out, or FIFO, basis. The Company uses actual costs to determine its cost basis for inventories. Inventories consist of only finished goods.

Capitalized Software Development Costs: Software development costs for internal-use software are accounted for in accordance with Accounting Standards Codification (“ASC”) 350-40, Internal-Use Software. Development costs that are incurred during the application development stage begin to be capitalized when two criteria are met: (i) the preliminary project stage is completed and (ii) it is probable that the software will be completed and used for its intended function. Capitalization ceases once the software is substantially complete and ready for its intended use. Costs incurred during the preliminary project stage of software development and post-implementation operating stages are expensed as incurred. Amortization is calculated on a straight-line basis over the remaining economic life of the software (typically three to five years) and will be included in the operating expenses on the condensed consolidated Statements of Operations once amortization begins. The estimated useful lives of software are reviewed at least annually and will be tested for impairment whenever events or changes in circumstances occur that could impact the recoverability of the assets. Capitalized software development costs for internal-use software totaled $223,390 as of March 31, 2022 and $186,271 as of December 31, 2021. The software application is still in development with costs continuing to be capitalized and no amortization expense being recognized during the periods ended March 31, 2022 and December 31, 2021. There were no impairments recognized during the periods ended March 31, 2022 and December 31, 2021. Intangible Assets: Intangible assets represent the value the Company paid to acquire assets including a trademark, patent and web domain on June 23, 2021. The allocation of the purchase price to each of these assets was determined based on ASC 805-50-30, Business Combination, Related Issues, Initial Measurement. These assets are accounted for in accordance with ASC 350-30, Intangibles, General Intangibles Other Than Goodwill. The cost of the assets is amortized over the remaining useful life of the assets as follows: Schedule of Indefinite-Lived Intangible Assets <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20%">U.S. Method Patent</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zHxEmFIOfDP4" title="Finite-lived intangible assets, amortization method">13.4 years</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Web Domain</td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--ImpairedIntangibleAssetDescription_c20220101__20220331__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebDomainMember_z5IXdDHO6vS2" title="Impaired intangible asset">Indefinite life</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Trademark</td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ImpairedIntangibleAssetDescription_c20220101__20220331__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zpq8VzILfMxi" title="Impaired intangible asset">Indefinite life</td></tr> </table> The estimated useful lives and carrying value of the assets are reviewed at least annually or whenever events or circumstances may result in an impact to the value of the assets. Convertible Notes Payable: The Company accounts for convertible notes deemed conventional and conversion options embedded in non-conventional convertible notes which qualify as equity under ASC 815, Derivatives and Hedging, in accordance with the provisions of ASC 470-20, Debt with Conversion and Other Options, which provides guidance on accounting for convertible securities with beneficial conversion features. ASC 470-20 addresses classification determination for specific obligations, such as short-term obligations expected to be refinanced on a long-term basis, due-on-demand loan arrangements, callable debt, sales of future revenue, increasing rate debt, debt that includes covenants, revolving credit agreements subject to lock-box arrangements and subjective acceleration clauses. Accordingly, the Company records, as a discount to convertible notes, the intrinsic value of such conversion options based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt.

223390

186271

Schedule of Indefinite-Lived Intangible Assets <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20%">U.S. Method Patent</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zHxEmFIOfDP4" title="Finite-lived intangible assets, amortization method">13.4 years</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Web Domain</td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--ImpairedIntangibleAssetDescription_c20220101__20220331__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebDomainMember_z5IXdDHO6vS2" title="Impaired intangible asset">Indefinite life</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Trademark</td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ImpairedIntangibleAssetDescription_c20220101__20220331__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zpq8VzILfMxi" title="Impaired intangible asset">Indefinite life</td></tr> </table>

P13Y4M24D

Indefinite life

Revenue Recognition: Pursuant to ASC Topic 606, Revenue from Contracts with Customers, or ASC 606, the Company recognizes revenue upon transfer of control of goods, in an amount that reflects the consideration that is expected to be received in exchange for those goods. The Company does not allow for the return of products and therefore does not establish an allowance for returns. To determine the revenue to be recognized for transactions that the Company determines are within the scope of ASC 606, the Company follows the established five-step framework as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.5in">(i)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">identify the contract(s) with a customer;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(ii)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">identify the performance obligations in the contract(s);</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(iii)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">determine the transaction price;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(iv)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">allocate the transaction price to the performance obligations in the contract(s); and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(v)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">recognize revenue when (or as) the Company satisfies a performance obligation.</td></tr> </table> The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians. Revenue is recognized once the Company satisfies its performance obligation which occurs at the point in time when title and possession of products have transitioned to the customer, typically upon delivery of the products. The Company includes shipping and handling fees billed to customers in revenue. There are several practical expedients and exemptions allowed under ASC 606 that impact timing of revenue recognition and disclosures. The Company elected to treat similar contracts as a portfolio of contracts, as allowed under ASC 606. The contracts that fall within the portfolio have the same terms and management has the expectation that the result will not be materially different from the consideration of each individual contract.

Research and Development: Research and development expense is primarily related to developing and improving methods related to the Company’s Software as a Service (SaaS) platform. Research and development expenses are expensed when incurred. For the three months ended March 31, 2022 and 2021, there were $28,979 and $28,021 of research and development expenses incurred, respectively.

28979

28021

Stock-based Compensation: The Company applies the fair value method of ASC 718, Share Based Payment, in accounting for its stock-based compensation. The standard states that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values stock-based compensation at the market price for the Company’s common stock and other pertinent factors at the grant date.

Earnings Per Common Share: Basic net loss per share is computed using the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed using the weighted average number of common and dilutive equivalent shares outstanding during the period. Dilutive common equivalent shares consist of options and warrants to purchase common stock (only if those options and warrants are exercisable and at prices below the average share price for the period) and shares issuable upon the conversion of issued and outstanding preferred stock. Due to the net losses reported, dilutive common equivalent shares were excluded from the computation of diluted loss per share, as inclusion would be anti-dilutive for the periods presented. There were <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20220101__20220331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zQuBiggEQMJ7" title="Common stock equivalent shares of weighted average shares outstanding dilutive"><span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zurDzV0gsLe7" title="Common stock equivalent shares of weighted average shares outstanding dilutive">no common equivalent shares required to be added to the basic weighted average shares outstanding to arrive at diluted weighted average shares outstanding as of March 31, 2022 or 2021.

Income Taxes: The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available tax benefits not expected to be realized. The Company has net operating losses of $2,709,199 which begin to expire in 2027. Future utilization of currently generated federal and state NOL and tax credit carry forwards may be subject to a substantial annual limitation due to the ownership change limitations. The annual limitation may result in the expiration of NOL and tax credit carry-forwards before full utilization.

2709199

begin to expire in 2027

Recently Issued Accounting Standards In August 2020, the Financial Accounts Standards Board (“FASB”) issued Accounting Standards Updates (“ASU”) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40), or ASU 2020-06. The updated guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. Consequently, more convertible debt instruments will be reported as single liability instruments with no separate accounting for embedded conversion features. The ASU 2020-06 also removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. In addition, ASU 2020-06 also simplifies the diluted net income per share calculation in certain areas. The Company adopted the provisions of ASU 2020-06 using a modified retrospective approach, which resulted in no cumulative effect adjustment to stockholders’ deficit as of January 1, 2021. This Quarterly Report on Form 10-Q does not discuss recent pronouncements that are not anticipated to have a current and/or future impact on or are unrelated to the Company’s financial condition, results of operations, cash flows or disclosures.

Note 4. Capitalized Software and Intangible Assets Non-current assets consist of the following at March 31, 2022 and December 31, 2021: Schedule of Intangible Assets <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Estimated Useful Life (in years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220331_zkeZ0ar5WsN" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20211231_zYSIg8pK52i1" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zAvkkQiYPFh6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Capitalized Software</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">TBD</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">223,390</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">186,271</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNetAbstract_iB_zjy5ZQnfaqOf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Intangible Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zzolEwWHCPh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">U.S. Method Patent</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zRhbZXTDsqEk" title="Finite-lived intangible assets, amortization method">13.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">967,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">967,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebDomainMember_zyL3eCSkiaDi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Web Domain</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,250</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zWSIjmwepfdc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Trademark</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">N/A</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">483,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">483,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maFLIANzGJu_z0lxBWGNjHPk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Intangible Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,612,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,612,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msFLIANzGJu_zsAxmlV3g5gl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(54,084</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,056</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzGJu_zbl5Rx8o20Rj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Intangible assets, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,558,416</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,576,444</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> Capitalized software represents the development costs for internal-use software. The software application is still in development with costs continuing to be capitalized and no amortization expense being recognized yet. Capitalization will cease and amortization will begin once development is substantially complete. The Capitalized software costs will be amortized over the estimated life of the software. There were no impairments recognized during the periods ended March 31, 2022 and December 31, 2021. The intangible assets represent the value the Company paid to acquire the trademark “AllergiEnd”, the web domain “AllergiEnd.com” along with the U.S. Method Patent registration relating to the allergy testing kit and related materials the Company distributes to physician clients. The Company acquired the intangible assets from MedScience Research Group as of June 23, 2021 for total consideration of $1,612,500 which was financed through a combination of restricted stock and a promissory note. The allocation of the purchase price to each of these assets was determined based on ASC 805-50-30, Business Combination, Related Issues, Initial Measurement. The assets are being amortized over their useful lives beginning July 1, 2021. The Trademark and Web Domain are determined to have an indefinite life and will be tested annually for impairment in accordance with ASC 350-30-35, Intangibles, General Intangibles Other Than Goodwill. There was $18,028 of amortization expense during the quarter ended March 31, 2022 and no amortization expense during the quarter ended March 31, 2021.

Non-current assets consist of the following at March 31, 2022 and December 31, 2021: Schedule of Intangible Assets <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Estimated Useful Life (in years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220331_zkeZ0ar5WsN" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20211231_zYSIg8pK52i1" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zAvkkQiYPFh6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Capitalized Software</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">TBD</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">223,390</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">186,271</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNetAbstract_iB_zjy5ZQnfaqOf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Intangible Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zzolEwWHCPh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">U.S. Method Patent</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zRhbZXTDsqEk" title="Finite-lived intangible assets, amortization method">13.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">967,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">967,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebDomainMember_zyL3eCSkiaDi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Web Domain</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,250</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zWSIjmwepfdc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Trademark</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">N/A</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">483,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">483,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maFLIANzGJu_z0lxBWGNjHPk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Intangible Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,612,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,612,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msFLIANzGJu_zsAxmlV3g5gl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(54,084</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,056</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzGJu_zbl5Rx8o20Rj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Intangible assets, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,558,416</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,576,444</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table>

223390

186271

P13Y4M24D

967500

161250

483750

1612500

54084

36056

1558416

1576444

1612500

18028

Note 5. Loans Payable On June 23, 2021, the Company entered into a purchase agreement to acquire certain assets from MedScience Research Group, Inc (“MedScience”) (See Note 4 for additional information). As part of that purchase agreement, the Company issued a Promissory Note with a principal sum of $750,000. The principal, along with associated interest, are being paid in 36 equal monthly installments that began in July 2021. The principal balance of the loan is divided between current and long-term liabilities on the Company’s condensed consolidated balance sheets. The combined principal due along with accrued interest as of March 31, 2022 is $586,716 and as of December 31, 2021 was $644,158. On March 2, 2022, the Company entered into a fixed-fee short-term loan with its merchant bank and received $128,500 in loan proceeds. The loan payable, which is split between current and long-term liabilities on the Company’s condensed consolidated balance sheets, is due in August 2023. The loan is repaid by the merchant bank withholding an agreed-upon percentage of payments they process on behalf of the Company with a minimum of $16,305 paid every 60 days. As of March 31, 2022, the loan balance is $117,117. The prior fixed-fee short-term loan with the same merchant bank had a balance of $16,793 as of December 31, 2021 and was paid in full during the first quarter 2022.

750000

586716

644158

128500

16305

117117

16793

Note 6. Convertible Notes Payable Convertible notes payable at March 31, 2022 and December 31, 2021, consist of the following: Schedule of Convertible Notes Payable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220331_zPW2l7ytJLD" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20211231_zLNCrCE7lwSh" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_zJyJ181uaYE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Note 1 – Accredited investors</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">25,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholderMember_zI5yMpD9HAvb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Note 2 – Shareholder</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableThreeMember__dei--LegalEntityAxis__custom--MercerStreetGlobalOpportunityFundLLCMember_zPPTbA8K81q3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Note 3 – Mercer Note</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">756,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">756,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleNotesPayable_iI_maCNPDDzvES_zAA8p3V8Qrlf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"/><td style="padding-bottom: 1.5pt; text-align: right">856,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"/><td style="padding-bottom: 1.5pt; text-align: right">881,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredFinanceCostsNet_iNI_di_msCNPDDzvES_z09UfBlaAXcj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Debt discount and issuance costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right">(142,046</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right">(238,896</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--ConvertibleNotesPayableDebtDiscountAndIssuanceCosts_iI_mtCNPDDzvES_zTDIVoRianCh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">713,954</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">642,104</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ConvertibleNotesPayableCurrent_iI_zHrIGMXv8ePe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Less: current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">613,954</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">542,104</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--ConvertibleLongTermNotesPayable_iI_zFpRnt3WXp49" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Note 1 – Effective December 23, 2020, the Company issued a Convertible Promissory Note in the principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201223__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_zB7HrVusY5hh">25,000 to a shareholder (Note 1). This Note was issued under a subscription agreement dated <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20201222__20201223__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_ztdPvDtsDrIh">September 25, 2020. As of March 31, 2022 and December 31, 2021, this note had $<span id="xdx_903_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20220331__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_z1lhTblsWgAc">0 and $<span id="xdx_90F_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20211231__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_ziZ11PKwveZ5">2,555, respectively, of accrued interest. On February 23, 2022 the shareholder elected to convert the outstanding principal of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220223__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_zyygYjws2NNh">25,000 along with accrued interest into <span id="xdx_904_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20220223__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_zbWs1VnA1zN2">59,415 shares of common stock at a price of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pip0_c20220223__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_zSQGYzlTW7f">0.47 per share. Additionally, the shareholder received warrants exercisable for two years to purchase <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pp0p0_c20220223__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_zIzIkrwfV4j9">14,854 common shares at $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pip0_c20220223__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_zid8fJFWAyOb">0.705 per share. Note 2 – Effective May 7, 2021, the Company issued a Convertible Promissory Note in the principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20210507__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholderMember_zjFYE9yomDsh">100,000 to a shareholder (Note 2). The Note bears interest at the rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210507__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholderMember_zchzvqexeMB5">10% per annum and matures on <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20210501__20210507__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholderMember_zFNUerg3SUn6">September 30, 2022 (the “Maturity Date”) at which date all outstanding principal and accrued and unpaid interest are due and payable. <span id="xdx_904_eus-gaap--DebtInstrumentDescription_c20210501__20210507__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholderMember_zAMWX0dMzshd">The Company may satisfy the Note upon maturity or Default, as defined, by the issuance of common shares at a conversion price equal to the greater of a 25% discount to the 15-day average market price of the Company’s common stock or $0.50. The principal and interest accrued are convertible at any time through the maturity date of September 30, 2022 at the option of the holder using the same conversion calculation. As of March 31, 2022 and December 31, 2021, this note had $<span id="xdx_900_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20220331__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholderMember_zobKMiv3o0ac">8,986 and $<span id="xdx_906_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20211231__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholderMember_zmTqMy69IYWl">6,521, respectively, of accrued interest. Note 3 – Effective August 10, 2021, the Company entered into a Securities Purchase Agreement with an accredited investor pursuant to which it issued to the investor an Original Issue Discount Secured Convertible Promissory Note (the “Note”) in the principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210810__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableThreeMember__dei--LegalEntityAxis__custom--MercerStreetGlobalOpportunityFundLLCMember_zDMVzWJkxnYi" title="Debt instrument, principal amount">806,000 and warrants to purchase <span id="xdx_901_ecustom--WarrantsIssuedToPurchaseOfCommonStock_iI_pp0p0_c20210810__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableThreeMember__dei--LegalEntityAxis__custom--MercerStreetGlobalOpportunityFundLLCMember_zUlFz3fL7Czg" title="Warrants to purchase common stock">930,000 shares of the Company’s common stock for aggregate consideration of $<span id="xdx_907_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20210801__20210810__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableThreeMember__dei--LegalEntityAxis__custom--MercerStreetGlobalOpportunityFundLLCMember_zMrbasIbvR58">750,000. In addition, pursuant to the Purchase Agreement the Company entered into a Registration Rights Agreement with the investor. The principal amount of the Note and all interest accrued thereon is payable on August 10, 2022, and are secured by a lien on substantially all of the Company’s assets. The Note provides for interest at the rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20220810__us-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteTenMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqWG3oBy3IMh" title="Debt instrument interest rate stated percentage">5% per annum, payable at maturity, and is convertible into common stock at a price of $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20220810__us-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteTenMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5GePC2nutSi" title="Debt instrument convertible conversion price1">0.65 per share. In addition to customary anti-dilution adjustments upon the occurrence of certain corporate events, the Note provides, subject to certain limited exceptions, that if we issue any common stock or common stock equivalents, as defined in the Note, at a per share price lower than the conversion price then in effect, the conversion price will be reduced to the per share price at which such stock or common stock equivalents were sold. The conversion price of the Note had been subject to a potential decrease if the average closing price of the Company’s common stock during any ten consecutive trading days beginning September 16, 2021, and ending on November 15, 2021, was below $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20211115__us-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteTenMember_zzRbrWtR6tZe" title="Debt instrument convertible conversion price1">0.65. As the trading price of the common stock has not been below $0.65 since September 21, 2021, this provision is no longer operative. On November 11, 2021, Mercer Street Global Opportunity Fund, LLC, converted $50,000 of the principal amount of the $806,000 Secured Convertible Promissory Note issued August 10, 2021, into 76,923 shares of the Company’s common stock at a price of $0.65 per share. The 930,000 Warrants are initially exercisable for a period of three years at a price of $1.25 per share, subject to customary anti-dilution adjustments upon the occurrence of certain corporate events as set forth in the Warrant. The shares issuable upon conversion of the Note and exercise of the Warrants are to be registered under the Securities Act of 1933, as amended, for resale by the investor as provided in the Registration Rights Agreement. The Warrants may be exercised by means of a “cashless exercise” if at any time the shares issuable upon exercise of the Warrant are not covered by an effective registration statement. The Company accounts for the allocation of its issuance costs to its Warrants in accordance with ASC 470-20, Debt with Conversion and Other Options. Under this guidance, if debt or stock is issued with detachable warrants, the proceeds need to be allocated to the two instruments using either the fair value method, the relative fair value method, or the residual value method. The Company used the relative fair value at the time of issuance to allocate the value received between the convertible note and the warrants. The Company estimated the fair value of the Warrants utilizing the Black-Scholes pricing model, which is dependent upon several assumptions such as the expected term of the Warrants, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected term and expected dividend yield rate over the expected term. The Company believes this valuation methodology is appropriate for estimating the fair value of warrants. The value allocated to the relative fair value of the Warrants was recorded as debt issuance costs and additional paid in capital. The principal, net of the original issue discount and debt issuance costs, including the allocated relative fair value of the Warrants, which are being recognized over the life of the Note, along with associated interest, is recorded with current liabilities on the Company’s condensed consolidated balance sheets. As of March 31, 2022, this Note had $24,767 of accrued interest, total unamortized debt issuance costs of $121,794, including the Warrant value, and the remaining discount of $20,252. As of December 31, 2021, this note had $15,446 of accrued interest, total unamortized debt issuance costs of $204,835, including the Warrant value, and the remaining discount of $34,060.

Convertible notes payable at March 31, 2022 and December 31, 2021, consist of the following: Schedule of Convertible Notes Payable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220331_zPW2l7ytJLD" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20211231_zLNCrCE7lwSh" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableOneMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_zJyJ181uaYE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Note 1 – Accredited investors</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">25,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholderMember_zI5yMpD9HAvb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Note 2 – Shareholder</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleNotesPayable_iI_hus-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesPayableThreeMember__dei--LegalEntityAxis__custom--MercerStreetGlobalOpportunityFundLLCMember_zPPTbA8K81q3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Note 3 – Mercer Note</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">756,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">756,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleNotesPayable_iI_maCNPDDzvES_zAA8p3V8Qrlf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"/><td style="padding-bottom: 1.5pt; text-align: right">856,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"/><td style="padding-bottom: 1.5pt; text-align: right">881,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredFinanceCostsNet_iNI_di_msCNPDDzvES_z09UfBlaAXcj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Debt discount and issuance costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right">(142,046</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right">(238,896</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_406_ecustom--ConvertibleNotesPayableDebtDiscountAndIssuanceCosts_iI_mtCNPDDzvES_zTDIVoRianCh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">713,954</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">642,104</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ConvertibleNotesPayableCurrent_iI_zHrIGMXv8ePe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Less: current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">613,954</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">542,104</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--ConvertibleLongTermNotesPayable_iI_zFpRnt3WXp49" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Non-current portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

25000

100000

756000

856000

881000

142046

238896

713954 642104

613954

542104

100000

25000

2020-09-25

2555

25000

59415

0.47

14854

0.705

100000

0.10

2022-09-30

The Company may satisfy the Note upon maturity or Default, as defined, by the issuance of common shares at a conversion price equal to the greater of a 25% discount to the 15-day average market price of the Company’s common stock or $0.50. The principal and interest accrued are convertible at any time through the maturity date of September 30, 2022 at the option of the holder using the same conversion calculation

8986

6521

806000

930000

750000

0.05

0.65

50000

806000

76923

0.65

930000

1.25

24767

121794

20252

15446

204835

34060

Note 7. Preferred Stock Series A Preferred Stock The shares of Series A Preferred Stock have a stated value of $0.25 per share and are initially convertible into shares of common stock at a price of $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20190901__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zHRlL2O3EU2f" title="Debt instrument, conversion price">0.05 per share (subject to adjustment upon the occurrence of certain events). <span id="xdx_90C_eus-gaap--PreferredStockVotingRights_c20190831__20190901__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z7Metr6HX6hf" title="Preferred stock voting rights description">The Series A Preferred Stock does not accrue dividends and ranks prior to the common stock upon a liquidation of the Company. The Series A Preferred Stock votes on all matters brought before the shareholders together with the Common stock as a single class and each share of Series A Preferred Stock has a number of votes, initially 5, equal to the number of shares of preferred stock into which it is convertible as of the record date for any vote. Series A-2 Preferred Stock On December 30, 2021, the Company issued 2,644,424 of the Company’s Series A-2 Convertible Preferred Shares to its principal shareholder in satisfaction of multiple outstanding convertible promissory notes with initial principal amounts totaling $286,078 together with all interest accrued thereon. The rights of holders of the Company’s common stock with respect to the payment of dividends and upon liquidation are junior in right of payment to holders of the Series A-2 Convertible Preferred Shares. The rights of the holders of the Company’s Series A-2 Preferred Shares are pari passu to the rights of the holders of the Company’s Series A Preferred Shares currently outstanding. Holders of the Series A-2 Convertible Preferred Stock will vote on an as converted basis with the holders of the Company’s common stock and Series A Preferred Shares as to all matters to be voted on by the holders of the common stock. Each Series A-2 Preferred Share shall be entitled to a number of votes equal to five times the number of shares of common stock into which it is then convertible on the applicable record date.

0.25

0.05

The Series A Preferred Stock does not accrue dividends and ranks prior to the common stock upon a liquidation of the Company. The Series A Preferred Stock votes on all matters brought before the shareholders together with the Common stock as a single class and each share of Series A Preferred Stock has a number of votes, initially 5, equal to the number of shares of preferred stock into which it is convertible as of the record date for any vote.

2644424

286078

Note 8. Loss Per Common Share The Company calculates net loss per common share in accordance with ASC 260, Earnings Per Share. Basic and diluted net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding during the period. The Company’s potentially dilutive shares, which include shares issuable upon exercise or conversion of outstanding common stock options, common stock warrants, and convertible debt have not been included in the computation of diluted net loss per share for the quarters ended March 31, 2022 and 2021 as the result would be anti-dilutive. <p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z95Ywy7U4bQ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none; text-align: justify"> </td><td style="display: none; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20220331_zAyGWMv8wk0e" style="border-bottom: Black 1.5pt solid; display: none; text-align: center">2022</td><td style="display: none; padding-bottom: 1.5pt"> </td><td style="display: none; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20210101__20210331_zmA8AGsKH1m2" style="border-bottom: Black 1.5pt solid; display: none; text-align: center">2021</td><td style="display: none; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zRHfgT87s0s9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,100,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">650,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockWarrantMember_zBK0r38l7iJ5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Stock warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,026,647</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z3ur1oo6CT7k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Total shares excluded from calculation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,126,647</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">650,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table>

<p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z95Ywy7U4bQ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none; text-align: justify"> </td><td style="display: none; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20220331_zAyGWMv8wk0e" style="border-bottom: Black 1.5pt solid; display: none; text-align: center">2022</td><td style="display: none; padding-bottom: 1.5pt"> </td><td style="display: none; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20210101__20210331_zmA8AGsKH1m2" style="border-bottom: Black 1.5pt solid; display: none; text-align: center">2021</td><td style="display: none; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zRHfgT87s0s9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Stock options</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,100,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">650,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockWarrantMember_zBK0r38l7iJ5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Stock warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,026,647</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z3ur1oo6CT7k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Total shares excluded from calculation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,126,647</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">650,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table>

1100000

650000

1026647

2126647

650000

Note 9. Stock-based Compensation During the three-month periods ended March 31, 2022 and 2021, there was $8,920 in stock-based compensation associated with stock options included in Research and development expense. Additionally, during the same periods there was expense associated with shares issued for services. The following table shows how the expenses associated with shares issued for services were classified in the condensed consolidated statements of operations during the respective periods. <p id="xdx_89E_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zlAuBQuhfrr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Schedule of Stock-based Compensation Expenses <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none; text-align: justify"> </td><td style="display: none; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220101__20220331_zJDoZQuJaxff" style="border-bottom: Black 1.5pt solid; display: none; text-align: center">2022</td><td style="display: none; padding-bottom: 1.5pt"> </td><td style="display: none; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20210101__20210331_zS2ciyQg9v03" style="border-bottom: Black 1.5pt solid; display: none; text-align: center">2021</td><td style="display: none; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zotvqUcmaFnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Research and development</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21,625</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_z2OGfl69LHH1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,187</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zyjTDESDHh9e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,484</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,581</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_zqyLknur0Lje" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total expense – shares issued for services</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,484</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">68,393</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> During the three months ended March 31, 2021 there were <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20210331__srt--TitleOfIndividualAxis__custom--ScientificAdvisorsMember_zb7eRVjERh4j" title="Number of options granted">450,000 options granted to certain scientific and business advisors (“Advisors”) with a weighted-average exercise price of $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20210331__srt--TitleOfIndividualAxis__custom--ScientificAdvisorsMember_ztX72MWpB2y3" title="Weighted-average exercise price">0.65. The options vest in equal annual installments over <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20210101__20210331__srt--TitleOfIndividualAxis__custom--ScientificAdvisorsMember_zBLyIRCFmgl" title="Options vesting term">three years beginning in April 2021 and expire <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dc_c20210101__20210331__srt--TitleOfIndividualAxis__custom--ScientificAdvisorsMember_zMCj9a5fE4Vi" title="Options expiration period">five years after grant date. There were no options exercised, forfeited or cancelled during the period. During the three months ended March 31, 2022 there were no options granted. As of March 31, 2022, there was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pp0p0_c20220331_zR4NvhACo1e9" title="Unrecognized compensation related to unvested options">27,164 of unrecognized compensation related to <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_pid_c20220331_z4kNSO7G9hTe" title="Unrecognized compensation related to unvested options, shares">1,100,000 outstanding options which is expected to be recognized over a weighted-average period of <span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtM_c20220101__20220331_zHBZ9im07fH1" title="Recognized weighted-average period">11 months. The options are being expensed over the vesting period for each Advisor. The weighted-average grant date fair value for options granted during the three months ended March 31, 2021 was $<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20210331_zeqlVhnmP3h1" title="Weighted-average fair value for options granted">0.12. The fair value of all options granted is determined using the Black-Scholes option-pricing model. The following weighted-average assumptions were used: Schedule of Fair Value of Option Grant of Weighted-average Assumptions <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended March 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 16%; text-align: center">N/A</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20210331_zMpJLnayXwS3" style="width: 16%; text-align: right" title="Risk-free interest rate">0.21</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected life of the options</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.5 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility of the underlying stock</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210101__20210331_zK9N31VszLR4" style="text-align: right" title="Expected volatility of the underlying stock">76.3</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend rate</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210101__20210331_zKQhTujRQ1f3" style="text-align: right" title="Expected dividend rate">0</td><td style="text-align: left">%</td></tr> </table> The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected term of the options. The expected life of the options is based on the option term. Due to the Company’s limited historical data, the expected volatility is calculated based upon the historical volatility of comparable companies whose share prices are publicly available for a sufficient period of time. The dividend rate is based on the Company never paying or having the intent to pay any cash dividends. <p id="xdx_89A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_z4r22YnDLuY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Options outstanding at March 31, 2022 consist of: Schedule of Options Outstanding and Exercisable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Date Issued</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number Exercisable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiration Date</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_zr1V8fEqrLD2" title="Date Issued">March 12, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_zuHjjOBqgHy" style="width: 16%; text-align: right" title="Number Outstanding">500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_z5HT363yGNxf" style="width: 16%; text-align: right" title="Number Exercisable">333,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_zzmGWukJ6mVi" style="width: 15%; text-align: right" title="Exercise Price">0.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 17%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_zT2vD5EbdOV1" title="Expiration Date">March 12, 2025</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zD9koRCsi0eg" title="Date Issued">June 27, 2020</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_z7O8aWBPiNe8" style="text-align: right" title="Number Outstanding">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_z28jsGPhM7sd" style="text-align: right" title="Number Exercisable">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zPnanIiR6ML2" style="text-align: right" title="Exercise Price">0.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_z4Pvy5HvTnLi" title="Expiration Date">June 27, 2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zG7LNtYLc587" title="Date Issued">January 1, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zjzMUmYCdms" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Outstanding">450,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zKXFAog5rwr7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Exercisable">150,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zYqWVUiN6fR8" style="padding-bottom: 1.5pt; text-align: right" title="Exercise Price">0.65</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: right; padding-bottom: 1.5pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zuUyrJ9LY20b" title="Expiration Date">December 31, 2025</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zi7l7tyz4JHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number Outstanding">1,100,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zZkZjVx8ZeZ2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number Exercisable">583,333</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td></tr> </table> Warrants outstanding at March 31, 2022 consist of: Schedule of Warrants Outstanding and Exercisable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Date Issued</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number Exercisable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiration Date</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zXBIDVSfPfSd" title="Date Issued">March 16, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zG8YBTOyikpl" style="width: 16%; text-align: right" title="Number Outstanding">15,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zY8BTiG8cB6e" style="width: 16%; text-align: right" title="Number Exercisable">15,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zATD6wB6mnsh" style="width: 15%; text-align: right" title="Exercise Price">0.75</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 17%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zsSyid3PrnEe" title="Expiration Date">March 15, 2023</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_zA0jRPZPvuvj" title="Date Issued">May 7, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_zoXxf6b848lk" style="text-align: right" title="Number Outstanding">53,704</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_zQMBZZAFQMh3" style="text-align: right" title="Number Exercisable">53,704</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_z7U7dw5JXVoh" style="text-align: right" title="Exercise Price">0.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_z9IQNwW13yWj" title="Expiration Date">May 6, 2023</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_z2YsHsssPjw4" title="Date Issued">June 17, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_z7KxT8AgqPH3" style="text-align: right" title="Number Outstanding">12,189</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_z8rGa7AVexG2" style="text-align: right" title="Number Exercisable">12,189</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_zVHSgDU1v5qc" style="text-align: right" title="Exercise Price">0.83</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_zuqzTukBaoD2" title="Expiration Date">June 16, 2023</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_ztrCaOYht49c" title="Date Issued">August 10, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_zNeCdhUzaIIg" style="text-align: right" title="Number Outstanding">930,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_z0PRZPNybZrk" style="text-align: right" title="Number Exercisable">930,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_zk1L0rnlaBJj" style="text-align: right" title="Exercise Price">1.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_zoZaH8wr4AE5" title="Expiration Date">August 9, 2024</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zpxhJT3ztX89" title="Date Issued">February 23, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zYsIY8LOuQHl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Outstanding">14,854</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zQHKaO2Km076" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Exercisable">14,854</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zVWHuQtLpigd" style="padding-bottom: 1.5pt; text-align: right" title="Exercise Price">0.705</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: right; padding-bottom: 1.5pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zIuzcoi0O9Kg" title="Expiration Date">February 22, 2024</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zdlvPACw5SIi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number Outstanding">1,026,647</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zP8D4qeuMrOe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number Exercisable">1,026,647</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> </table>

8920

<p id="xdx_89E_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zlAuBQuhfrr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Schedule of Stock-based Compensation Expenses <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none; text-align: justify"> </td><td style="display: none; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220101__20220331_zJDoZQuJaxff" style="border-bottom: Black 1.5pt solid; display: none; text-align: center">2022</td><td style="display: none; padding-bottom: 1.5pt"> </td><td style="display: none; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20210101__20210331_zS2ciyQg9v03" style="border-bottom: Black 1.5pt solid; display: none; text-align: center">2021</td><td style="display: none; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zotvqUcmaFnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Research and development</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21,625</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_z2OGfl69LHH1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,187</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zyjTDESDHh9e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,484</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,581</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_zqyLknur0Lje" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total expense – shares issued for services</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,484</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">68,393</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table>

21625

29187

3484

17581

3484

68393

450000

0.65

P3Y

P5Y

27164

1100000

P11M

0.12

The fair value of all options granted is determined using the Black-Scholes option-pricing model. The following weighted-average assumptions were used: Schedule of Fair Value of Option Grant of Weighted-average Assumptions <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended March 31, 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended March 31, 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 16%; text-align: center">N/A</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20210101__20210331_zMpJLnayXwS3" style="width: 16%; text-align: right" title="Risk-free interest rate">0.21</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected life of the options</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.5 years</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility of the underlying stock</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20210101__20210331_zK9N31VszLR4" style="text-align: right" title="Expected volatility of the underlying stock">76.3</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend rate</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">N/A</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20210101__20210331_zKQhTujRQ1f3" style="text-align: right" title="Expected dividend rate">0</td><td style="text-align: left">%</td></tr> </table>

0.0021

P3Y6M

0.763

<p id="xdx_89A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_z4r22YnDLuY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Options outstanding at March 31, 2022 consist of: Schedule of Options Outstanding and Exercisable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Date Issued</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number Exercisable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiration Date</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_zr1V8fEqrLD2" title="Date Issued">March 12, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_zuHjjOBqgHy" style="width: 16%; text-align: right" title="Number Outstanding">500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_z5HT363yGNxf" style="width: 16%; text-align: right" title="Number Exercisable">333,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_zzmGWukJ6mVi" style="width: 15%; text-align: right" title="Exercise Price">0.40</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 17%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionOneMember_zT2vD5EbdOV1" title="Expiration Date">March 12, 2025</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zD9koRCsi0eg" title="Date Issued">June 27, 2020</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_z7O8aWBPiNe8" style="text-align: right" title="Number Outstanding">150,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_z28jsGPhM7sd" style="text-align: right" title="Number Exercisable">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_zPnanIiR6ML2" style="text-align: right" title="Exercise Price">0.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionTwoMember_z4Pvy5HvTnLi" title="Expiration Date">June 27, 2025</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zG7LNtYLc587" title="Date Issued">January 1, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zjzMUmYCdms" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Outstanding">450,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zKXFAog5rwr7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Exercisable">150,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zYqWVUiN6fR8" style="padding-bottom: 1.5pt; text-align: right" title="Exercise Price">0.65</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: right; padding-bottom: 1.5pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--OptionThreeMember_zuUyrJ9LY20b" title="Expiration Date">December 31, 2025</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zi7l7tyz4JHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number Outstanding">1,100,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__us-gaap--OptionMember_zZkZjVx8ZeZ2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number Exercisable">583,333</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td></tr> </table>

2020-03-12

500000

333333

0.40

2025-03-12

2020-06-27

150000

100000

0.40

2025-06-27

2021-01-01

450000

150000

0.65

2025-12-31

1100000

583333

Warrants outstanding at March 31, 2022 consist of: Schedule of Warrants Outstanding and Exercisable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Date Issued</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number Exercisable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Expiration Date</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 22%"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zXBIDVSfPfSd" title="Date Issued">March 16, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zG8YBTOyikpl" style="width: 16%; text-align: right" title="Number Outstanding">15,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zY8BTiG8cB6e" style="width: 16%; text-align: right" title="Number Exercisable">15,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zATD6wB6mnsh" style="width: 15%; text-align: right" title="Exercise Price">0.75</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 17%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantOneMember_zsSyid3PrnEe" title="Expiration Date">March 15, 2023</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_zA0jRPZPvuvj" title="Date Issued">May 7, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_zoXxf6b848lk" style="text-align: right" title="Number Outstanding">53,704</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_zQMBZZAFQMh3" style="text-align: right" title="Number Exercisable">53,704</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_z7U7dw5JXVoh" style="text-align: right" title="Exercise Price">0.74</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_z9IQNwW13yWj" title="Expiration Date">May 6, 2023</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_z2YsHsssPjw4" title="Date Issued">June 17, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_z7KxT8AgqPH3" style="text-align: right" title="Number Outstanding">12,189</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_z8rGa7AVexG2" style="text-align: right" title="Number Exercisable">12,189</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_zVHSgDU1v5qc" style="text-align: right" title="Exercise Price">0.83</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_zuqzTukBaoD2" title="Expiration Date">June 16, 2023</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_ztrCaOYht49c" title="Date Issued">August 10, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_zNeCdhUzaIIg" style="text-align: right" title="Number Outstanding">930,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_z0PRZPNybZrk" style="text-align: right" title="Number Exercisable">930,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_zk1L0rnlaBJj" style="text-align: right" title="Exercise Price">1.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantFourMember_zoZaH8wr4AE5" title="Expiration Date">August 9, 2024</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zpxhJT3ztX89" title="Date Issued">February 23, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zYsIY8LOuQHl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Outstanding">14,854</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zQHKaO2Km076" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Exercisable">14,854</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice_iI_pid_c20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zVWHuQtLpigd" style="padding-bottom: 1.5pt; text-align: right" title="Exercise Price">0.705</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: right; padding-bottom: 1.5pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20220331__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_zIuzcoi0O9Kg" title="Expiration Date">February 22, 2024</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zdlvPACw5SIi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number Outstanding">1,026,647</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber_iI_pid_c20220331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zP8D4qeuMrOe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number Exercisable">1,026,647</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> </table>

2021-03-16

15900

15900 0.75

2023-03-15

2021-05-07

53704

53704 0.74

2023-05-06

2021-06-17

12189

12189 0.83

2023-06-16

2021-08-10

930000

930000 1.25

2024-08-09

2022-02-23

14854

14854 0.705

2024-02-22

1026647

Note 10. Related Party Transactions Convertible notes payable, related party: See Note 6.

Note 11. Income Taxes For the three month period ended March 31, 2022 and the year ended December 31, 2021, the Company did not record a tax provision as the Company did not earn any taxable income in either period and maintains a full valuation allowance against its net deferred tax assets.

Note 12. Commitments and Contingencies On February 9, 2021, the Company entered into a Receivables Purchase and Security Agreement (“Factoring Agreement”) with a Factoring Company. The Factoring Agreement has an initial term of one year and, in accordance with its terms, has been renewed for an additional year. Under the terms of the agreement, designated receivables are sold for periodic advances of up to $150,000. The Factoring Company retains a reserve of <span id="xdx_909_ecustom--ReserveOfPurchasedReceivables_iI_pid_dp_uPure_c20210209__us-gaap--TypeOfArrangementAxis__custom--FactoringAgreementMember_zbg7aiOkK6G1" title="Reserve of purchased receivables, percentage">10% of purchased receivables with the balance available to the Company. Factoring fees begin at 1.8% for the first 30 days a purchased invoice is outstanding and increase the longer an invoice remains outstanding. After 90 days, the Factoring Company has the right to assign the invoice back to the Company. The Factoring Agreement includes minimum average monthly volumes. As of March 31, 2022, the balance of outstanding invoices that the Factoring Company may assign back to the Company if not collected within 90 days is included in the Company’s Accounts Receivable balance with the amounts received, net of reserves held, included with other current liabilities on the condensed consolidated balance sheets. The net amount included in other current liabilities is $10,334 and $25,420 as of March 31, 2022 and December 31, 2021, respectively. There are no pending or threatened legal proceedings as of March 31, 2022. The Company has no non-cancellable operating leases.

P1Y 150000 0.10 0.018

10334

25420

EXCEL 49 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 120 198 1 false 42 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://usaqcorp.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://usaqcorp.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://usaqcorp.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://usaqcorp.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://usaqcorp.com/role/StatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://usaqcorp.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - The Company Sheet http://usaqcorp.com/role/Company The Company Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://usaqcorp.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Basis of Presentation Sheet http://usaqcorp.com/role/BasisOfPresentation Basis of Presentation Notes 9 false false R10.htm 00000010 - Disclosure - Capitalized Software and Intangible Assets Sheet http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssets Capitalized Software and Intangible Assets Notes 10 false false R11.htm 00000011 - Disclosure - Loans Payable Sheet http://usaqcorp.com/role/LoansPayable Loans Payable Notes 11 false false R12.htm 00000012 - Disclosure - Convertible Notes Payable Notes http://usaqcorp.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 12 false false R13.htm 00000013 - Disclosure - Preferred Stock Sheet http://usaqcorp.com/role/PreferredStock Preferred Stock Notes 13 false false R14.htm 00000014 - Disclosure - Loss Per Common Share Sheet http://usaqcorp.com/role/LossPerCommonShare Loss Per Common Share Notes 14 false false R15.htm 00000015 - Disclosure - Stock-based Compensation Sheet http://usaqcorp.com/role/Stock-basedCompensation Stock-based Compensation Notes 15 false false R16.htm 00000016 - Disclosure - Related Party Transactions Sheet http://usaqcorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 16 false false R17.htm 00000017 - Disclosure - Income Taxes Sheet http://usaqcorp.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 00000018 - Disclosure - Commitments and Contingencies Sheet http://usaqcorp.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 00000019 - Disclosure - Basis of Presentation (Policies) Sheet http://usaqcorp.com/role/BasisOfPresentationPolicies Basis of Presentation (Policies) Policies 19 false false R20.htm 00000020 - Disclosure - Basis of Presentation (Tables) Sheet http://usaqcorp.com/role/BasisOfPresentationTables Basis of Presentation (Tables) Tables http://usaqcorp.com/role/BasisOfPresentation 20 false false R21.htm 00000021 - Disclosure - Capitalized Software and Intangible Assets (Tables) Sheet http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssetsTables Capitalized Software and Intangible Assets (Tables) Tables http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssets 21 false false R22.htm 00000022 - Disclosure - Convertible Notes Payable (Tables) Notes http://usaqcorp.com/role/ConvertibleNotesPayableTables Convertible Notes Payable (Tables) Tables http://usaqcorp.com/role/ConvertibleNotesPayable 22 false false R23.htm 00000023 - Disclosure - Loss Per Common Share (Tables) Sheet http://usaqcorp.com/role/LossPerCommonShareTables Loss Per Common Share (Tables) Tables http://usaqcorp.com/role/LossPerCommonShare 23 false false R24.htm 00000024 - Disclosure - Stock-based Compensation (Tables) Sheet http://usaqcorp.com/role/Stock-basedCompensationTables Stock-based Compensation (Tables) Tables http://usaqcorp.com/role/Stock-basedCompensation 24 false false R25.htm 00000025 - Disclosure - Schedule of Indefinite-Lived Intangible Assets (Details) Sheet http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails Schedule of Indefinite-Lived Intangible Assets (Details) Details 25 false false R26.htm 00000026 - Disclosure - Basis of Presentation (Details Narrative) Sheet http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative Basis of Presentation (Details Narrative) Details http://usaqcorp.com/role/BasisOfPresentationTables 26 false false R27.htm 00000027 - Disclosure - Schedule of Intangible Assets (Details) Sheet http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails Schedule of Intangible Assets (Details) Details 27 false false R28.htm 00000028 - Disclosure - Capitalized Software and Intangible Assets (Details Narrative) Sheet http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssetsDetailsNarrative Capitalized Software and Intangible Assets (Details Narrative) Details http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssetsTables 28 false false R29.htm 00000029 - Disclosure - Loans Payable (Details Narrative) Sheet http://usaqcorp.com/role/LoansPayableDetailsNarrative Loans Payable (Details Narrative) Details http://usaqcorp.com/role/LoansPayable 29 false false R30.htm 00000030 - Disclosure - Schedule of Convertible Notes Payable (Details) Notes http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails Schedule of Convertible Notes Payable (Details) Details 30 false false R31.htm 00000031 - Disclosure - Convertible Notes Payable (Details Narrative) Notes http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative Convertible Notes Payable (Details Narrative) Details http://usaqcorp.com/role/ConvertibleNotesPayableTables 31 false false R32.htm 00000032 - Disclosure - Preferred Stock (Details Narrative) Sheet http://usaqcorp.com/role/PreferredStockDetailsNarrative Preferred Stock (Details Narrative) Details http://usaqcorp.com/role/PreferredStock 32 false false R33.htm 00000033 - Disclosure - Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share (Details) Sheet http://usaqcorp.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationOfEarningPerShareDetails Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share (Details) Details 33 false false R34.htm 00000034 - Disclosure - Schedule of Stock-based Compensation Expenses (Details) Sheet http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails Schedule of Stock-based Compensation Expenses (Details) Details 34 false false R35.htm 00000035 - Disclosure - Schedule of Fair Value of Option Grant of Weighted-average Assumptions (Details) Sheet http://usaqcorp.com/role/ScheduleOfFairValueOfOptionGrantOfWeighted-averageAssumptionsDetails Schedule of Fair Value of Option Grant of Weighted-average Assumptions (Details) Details 35 false false R36.htm 00000036 - Disclosure - Schedule of Options Outstanding and Exercisable (Details) Sheet http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails Schedule of Options Outstanding and Exercisable (Details) Details 36 false false R37.htm 00000037 - Disclosure - Schedule of Warrants Outstanding and Exercisable (Details) Sheet http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails Schedule of Warrants Outstanding and Exercisable (Details) Details 37 false false R38.htm 00000038 - Disclosure - Stock-based Compensation (Details Narrative) Sheet http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative Stock-based Compensation (Details Narrative) Details http://usaqcorp.com/role/Stock-basedCompensationTables 38 false false R39.htm 00000039 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://usaqcorp.com/role/CommitmentsAndContingencies 39 false false All Reports Book All Reports form10-q.htm ex31.htm ex32.htm usaq-20220331.xsd usaq-20220331_cal.xml usaq-20220331_def.xml usaq-20220331_lab.xml usaq-20220331_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 54 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 15, "contextCount": 120, "dts": { "calculationLink": { "local": [ "usaq-20220331_cal.xml" ] }, "definitionLink": { "local": [ "usaq-20220331_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "usaq-20220331_lab.xml" ] }, "presentationLink": { "local": [ "usaq-20220331_pre.xml" ] }, "schema": { "local": [ "usaq-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 345, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 65, "http://usaqcorp.com/20220331": 5, "http://xbrl.sec.gov/dei/2022": 4, "total": 74 }, "keyCustom": 15, "keyStandard": 183, "memberCustom": 25, "memberStandard": 14, "nsprefix": "USAQ", "nsuri": "http://usaqcorp.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://usaqcorp.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Capitalized Software and Intangible Assets", "role": "http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssets", "shortName": "Capitalized Software and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "USAQ:LoansPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Loans Payable", "role": "http://usaqcorp.com/role/LoansPayable", "shortName": "Loans Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "USAQ:LoansPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Convertible Notes Payable", "role": "http://usaqcorp.com/role/ConvertibleNotesPayable", "shortName": "Convertible Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Preferred Stock", "role": "http://usaqcorp.com/role/PreferredStock", "shortName": "Preferred Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Loss Per Common Share", "role": "http://usaqcorp.com/role/LossPerCommonShare", "shortName": "Loss Per Common Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Stock-based Compensation", "role": "http://usaqcorp.com/role/Stock-basedCompensation", "shortName": "Stock-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Related Party Transactions", "role": "http://usaqcorp.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Income Taxes", "role": "http://usaqcorp.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Commitments and Contingencies", "role": "http://usaqcorp.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Basis of Presentation (Policies)", "role": "http://usaqcorp.com/role/BasisOfPresentationPolicies", "shortName": "Basis of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://usaqcorp.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Basis of Presentation (Tables)", "role": "http://usaqcorp.com/role/BasisOfPresentationTables", "shortName": "Basis of Presentation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Capitalized Software and Intangible Assets (Tables)", "role": "http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssetsTables", "shortName": "Capitalized Software and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Convertible Notes Payable (Tables)", "role": "http://usaqcorp.com/role/ConvertibleNotesPayableTables", "shortName": "Convertible Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Loss Per Common Share (Tables)", "role": "http://usaqcorp.com/role/LossPerCommonShareTables", "shortName": "Loss Per Common Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Stock-based Compensation (Tables)", "role": "http://usaqcorp.com/role/Stock-basedCompensationTables", "shortName": "Stock-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_WebDomainMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ImpairedIntangibleAssetDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Schedule of Indefinite-Lived Intangible Assets (Details)", "role": "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails", "shortName": "Schedule of Indefinite-Lived Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_WebDomainMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ImpairedIntangibleAssetDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Basis of Presentation (Details Narrative)", "role": "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative", "shortName": "Basis of Presentation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "lang": null, "name": "us-gaap:CapitalizedComputerSoftwareAmortization1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Schedule of Intangible Assets (Details)", "role": "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails", "shortName": "Schedule of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalizedComputerSoftwareImpairments1", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Capitalized Software and Intangible Assets (Details Narrative)", "role": "http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssetsDetailsNarrative", "shortName": "Capitalized Software and Intangible Assets (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-06-222021-06-23", "decimals": "0", "lang": null, "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "span", "p", "USAQ:LoansPayableTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtDefaultLongtermDebtAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Loans Payable (Details Narrative)", "role": "http://usaqcorp.com/role/LoansPayableDetailsNarrative", "shortName": "Loans Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "USAQ:LoansPayableTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtDefaultLongtermDebtAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://usaqcorp.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Schedule of Convertible Notes Payable (Details)", "role": "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails", "shortName": "Schedule of Convertible Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Convertible Notes Payable (Details Narrative)", "role": "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "shortName": "Convertible Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-09-01_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Preferred Stock (Details Narrative)", "role": "http://usaqcorp.com/role/PreferredStockDetailsNarrative", "shortName": "Preferred Stock (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-09-01_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share (Details)", "role": "http://usaqcorp.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationOfEarningPerShareDetails", "shortName": "Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_StockOptionsMember", "decimals": "INF", "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Schedule of Stock-based Compensation Expenses (Details)", "role": "http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails", "shortName": "Schedule of Stock-based Compensation Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Schedule of Fair Value of Option Grant of Weighted-average Assumptions (Details)", "role": "http://usaqcorp.com/role/ScheduleOfFairValueOfOptionGrantOfWeighted-averageAssumptionsDetails", "shortName": "Schedule of Fair Value of Option Grant of Weighted-average Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-012021-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_OptionOneMember", "decimals": null, "first": true, "lang": "en-US", "name": "USAQ:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Schedule of Options Outstanding and Exercisable (Details)", "role": "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails", "shortName": "Schedule of Options Outstanding and Exercisable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_OptionOneMember", "decimals": null, "first": true, "lang": "en-US", "name": "USAQ:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_WarrantOneMember", "decimals": null, "first": true, "lang": "en-US", "name": "USAQ:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Schedule of Warrants Outstanding and Exercisable (Details)", "role": "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "shortName": "Schedule of Warrants Outstanding and Exercisable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_WarrantOneMember", "decimals": null, "first": true, "lang": "en-US", "name": "USAQ:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Stock-based Compensation (Details Narrative)", "role": "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative", "shortName": "Stock-based Compensation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherLiabilitiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Commitments and Contingencies (Details Narrative)", "role": "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-02-092021-02-09_custom_FactoringAgreementMember", "decimals": null, "lang": "en-US", "name": "USAQ:AgreementTermPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://usaqcorp.com/role/StatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "role": "http://usaqcorp.com/role/StatementsOfStockholdersEquity", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://usaqcorp.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - The Company", "role": "http://usaqcorp.com/role/Company", "shortName": "The Company", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Going Concern", "role": "http://usaqcorp.com/role/GoingConcern", "shortName": "Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Basis of Presentation", "role": "http://usaqcorp.com/role/BasisOfPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 42, "tag": { "USAQ_AccreditedInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accredited Investor [Member]", "label": "Accredited Investor [Member]" } } }, "localname": "AccreditedInvestorMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "USAQ_AccruedInterestExpensesNonCurrent": { "auth_ref": [], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued interest expenses non current.", "label": "Accrued interest expenses" } } }, "localname": "AccruedInterestExpensesNonCurrent", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "USAQ_AdvancesOnSaleOnReceivables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Advances on sale on receivables.", "label": "Advances on sale on receivables" } } }, "localname": "AdvancesOnSaleOnReceivables", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "USAQ_AgreementTermPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement term period.", "label": "Agreement term" } } }, "localname": "AgreementTermPeriod", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "USAQ_AmortizationOfUnearnedCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization of unearned compensation.", "label": "Amortization of unearned compensation" } } }, "localname": "AmortizationOfUnearnedCompensation", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "USAQ_ConvertibleNotesPayableDebtDiscountAndIssuanceCosts": { "auth_ref": [], "calculation": { "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total convertible notes payable" } } }, "localname": "ConvertibleNotesPayableDebtDiscountAndIssuanceCosts", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "USAQ_ConvertibleNotesPayableOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Notes Payable One [Member]", "label": "Convertible Notes Payable One [Member]" } } }, "localname": "ConvertibleNotesPayableOneMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "USAQ_ConvertibleNotesPayableThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Notes Payable Three [Member]", "label": "Convertible Notes Payable Three [Member]" } } }, "localname": "ConvertibleNotesPayableThreeMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "USAQ_ConvertibleNotesPayableTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Notes Payable Two [Member]", "label": "Convertible Notes Payable Two [Member]" } } }, "localname": "ConvertibleNotesPayableTwoMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "USAQ_ConvertiblePromissoryNoteTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Promissory Note Ten [Member]", "label": "Convertible Promissory Note Ten [Member]" } } }, "localname": "ConvertiblePromissoryNoteTenMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "USAQ_DebtAndAccruedInterestConvertedToSharesOfCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt and accrued interest converted to shares of common stock.", "label": "Debt and accrued interest converted to shares of common stock" } } }, "localname": "DebtAndAccruedInterestConvertedToSharesOfCommonStock", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "USAQ_DisclosureLoansPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loans Payable" } } }, "localname": "DisclosureLoansPayableAbstract", "nsuri": "http://usaqcorp.com/20220331", "xbrltype": "stringItemType" }, "USAQ_FactoringAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Factoring Agreement [Member]", "label": "Factoring Agreement [Member]" } } }, "localname": "FactoringAgreementMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "USAQ_FactoringFees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Factoring fees.", "label": "Factoring fees, percentage" } } }, "localname": "FactoringFees", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "USAQ_LoansPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loans Payable [Text Block]", "label": "Loans Payable [Text Block]", "verboseLabel": "Loans Payable" } } }, "localname": "LoansPayableTextBlock", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/LoansPayable" ], "xbrltype": "textBlockItemType" }, "USAQ_MercerStreetGlobalOpportunityFundLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mercer Street Global Opportunity Fund LLC [Member]", "label": "Mercer Street Global Opportunity Fund LLC [Member]" } } }, "localname": "MercerStreetGlobalOpportunityFundLLCMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "USAQ_MerchantBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Merchant Bank [Member]" } } }, "localname": "MerchantBankMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "USAQ_NetOperatingLossesCarryforwardsExpireDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net operating losses carryforwards expire date.", "label": "Net operating losses carryforwards, expire date" } } }, "localname": "NetOperatingLossesCarryforwardsExpireDate", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "stringItemType" }, "USAQ_OptionOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option One [Member]", "label": "Option One [Member]" } } }, "localname": "OptionOneMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "USAQ_OptionThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option Three [Member]", "label": "Option Three [Member]" } } }, "localname": "OptionThreeMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "USAQ_OptionTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option Two [Member]", "label": "Option Two [Member]" } } }, "localname": "OptionTwoMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "USAQ_PurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase Agreement [Member]", "label": "Purchase Agreement [Member]" } } }, "localname": "PurchaseAgreementMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "USAQ_ReserveOfPurchasedReceivables": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reserve of purchased receivables.", "label": "Reserve of purchased receivables, percentage" } } }, "localname": "ReserveOfPurchasedReceivables", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "USAQ_ScientificAdvisorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scientific Advisors [Member]", "label": "Scientific Advisors [Member]" } } }, "localname": "ScientificAdvisorsMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "USAQ_SeriesA2ConvertiblePreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A2 Convertible Preferred Shares [Member]", "label": "Series A2 Convertible Preferred Shares [Member]" } } }, "localname": "SeriesA2ConvertiblePreferredSharesMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "USAQ_SeriesATwoPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A-2 Preferred Stock [Member]", "label": "Series A-2 Preferred Stock [Member]" } } }, "localname": "SeriesATwoPreferredStockMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/BalanceSheetsParenthetical", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "USAQ_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award option issuance date.", "label": "Date Issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionIssuanceDate", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails" ], "xbrltype": "dateItemType" }, "USAQ_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award warrants exercisable number.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber", "verboseLabel": "Number Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "sharesItemType" }, "USAQ_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award warrants issuance date.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate", "verboseLabel": "Date Issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsIssuanceDate", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "dateItemType" }, "USAQ_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award warrants outstanding weighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice", "verboseLabel": "Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "perShareItemType" }, "USAQ_ShareholderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholder [Member]", "label": "Shareholder [Member]" } } }, "localname": "ShareholderMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "USAQ_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options [Member]", "label": "Stock Options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationOfEarningPerShareDetails" ], "xbrltype": "domainItemType" }, "USAQ_StockWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Warrant [Member]", "label": "Stock Warrant [Member]" } } }, "localname": "StockWarrantMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationOfEarningPerShareDetails" ], "xbrltype": "domainItemType" }, "USAQ_UnearnedStockCompensationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unearned Stock Compensation [Member]", "label": "Unearned Stock Compensation [Member]" } } }, "localname": "UnearnedStockCompensationMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "USAQ_WarrantFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Five [Member]", "label": "Warrant Five [Member]" } } }, "localname": "WarrantFiveMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "USAQ_WarrantFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Four [Member]", "label": "Warrant Four [Member]" } } }, "localname": "WarrantFourMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "USAQ_WarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant One [Member]", "label": "Warrant One [Member]" } } }, "localname": "WarrantOneMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "USAQ_WarrantThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Three [Member]", "label": "Warrant Three [Member]" } } }, "localname": "WarrantThreeMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "USAQ_WarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Two [Member]", "label": "Warrant Two [Member]" } } }, "localname": "WarrantTwoMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "USAQ_WarrantsIssuedToPurchaseOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants issued to purchase of common stock.", "label": "Warrants to purchase common stock" } } }, "localname": "WarrantsIssuedToPurchaseOfCommonStock", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "USAQ_WebDomainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Web Domain [Member]", "label": "Web Domain [Member]" } } }, "localname": "WebDomainMember", "nsuri": "http://usaqcorp.com/20220331", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails", "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r411", "r413", "r414" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://usaqcorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r137", "r341" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r29", "r347" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r138", "r139" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r21", "r347" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r79", "r80", "r81", "r284", "r285", "r286", "r317" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r183", "r219", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Warrants issued with conversion of notes payable" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash from operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r279" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Total expense \u2013 shares issued for services" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r51", "r65", "r198", "r333" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of debt and warrant issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Common stock equivalent shares of weighted average shares outstanding dilutive", "verboseLabel": "Total shares excluded from calculation" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationOfEarningPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationOfEarningPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationOfEarningPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationOfEarningPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r13", "r76", "r123", "r126", "r132", "r145", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r311", "r314", "r321", "r345", "r347", "r367", "r379" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r28", "r76", "r145", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r311", "r314", "r321", "r345", "r347" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current assets:" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r248", "r249", "r250", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r269", "r270", "r273", "r274", "r275", "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails", "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedComputerSoftwareAmortization1": { "auth_ref": [ "r395", "r398" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for amortization of capitalized computer software costs.", "label": "Capitalized computer software, amortization" } } }, "localname": "CapitalizedComputerSoftwareAmortization1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareImpairments1": { "auth_ref": [ "r396", "r398" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss from capitalized computer software costs.", "label": "Capitalized computer software, impairments" } } }, "localname": "CapitalizedComputerSoftwareImpairments1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative", "http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers": { "auth_ref": [ "r366", "r378", "r394" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unamortized costs incurred for development of computer software, which is to be sold, leased or otherwise marketed, after establishing technological feasibility through to the general release of the software products. Excludes capitalized costs of developing software for internal use.", "label": "Capitalized software development costs", "verboseLabel": "Capitalized software development costs for software sold to customers" } } }, "localname": "CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r11", "r67" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r60", "r67", "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents - end of period", "periodStartLabel": "Cash and cash equivalents \u2013 beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r60", "r322" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental noncash investing and financing activity:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r18", "r19", "r20", "r75", "r76", "r93", "r94", "r95", "r97", "r99", "r108", "r109", "r110", "r145", "r172", "r176", "r177", "r178", "r181", "r182", "r212", "r213", "r216", "r217", "r219", "r321", "r416" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/BalanceSheetsParenthetical", "http://usaqcorp.com/role/PreferredStockDetailsNarrative", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r37", "r371", "r384" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitment and contingencies (Note 12)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r167", "r168", "r169", "r170", "r393" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r79", "r80", "r317" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r20", "r219" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r20", "r347" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, 900,000,000 shares authorized, $0.0001 par value; 8,815,508 and 8,756,093 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r151", "r156", "r308" ], "lang": { "en-us": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r71", "r313" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Schedule of Convertible Notes Payable" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r36" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable, non-current portion", "verboseLabel": "Non-current portion" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r16", "r369", "r381", "r392" ], "calculation": { "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails": { "order": 1.0, "parentTag": "USAQ_ConvertibleNotesPayableDebtDiscountAndIssuanceCosts", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Total" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable, current portion", "verboseLabel": "Less: current portion" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r53", "r76", "r145", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r321" ], "calculation": { "http://usaqcorp.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDefaultLongtermDebtAmount": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured.", "label": "Debt default longterm debt amount" } } }, "localname": "DebtDefaultLongtermDebtAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r74", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r196", "r199", "r200", "r201", "r208" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Convertible Notes Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r186", "r203" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt instrument convertible conversion price1", "verboseLabel": "Debt instrument, conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r15", "r16", "r220", "r368", "r369", "r375", "r377" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt Instrument, Description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r184", "r204", "r205", "r332", "r334", "r335" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument face amount", "terseLabel": "Debt Instrument, Face Amount", "verboseLabel": "Debt instrument, principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/LoansPayableDetailsNarrative", "http://usaqcorp.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r34", "r185" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt instrument interest rate stated percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r35", "r187", "r320" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r195", "r331", "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r195", "r202", "r204", "r205", "r333" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationEquity": { "auth_ref": [ "r40", "r244" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued under share-based plans to employees or officers which is the unearned portion, accounted for under the fair value method.", "label": "Deferred Compensation Equity", "negatedLabel": "Unearned stock compensation" } } }, "localname": "DeferredCompensationEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r195", "r333" ], "calculation": { "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails": { "order": 2.0, "parentTag": "USAQ_ConvertibleNotesPayableDebtDiscountAndIssuanceCosts", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedLabel": "Debt discount and issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r65", "r164" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://usaqcorp.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Amortization", "verboseLabel": "Amortization expense" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssetsDetailsNarrative", "http://usaqcorp.com/role/StatementsOfCashFlows", "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r247", "r248", "r280", "r281", "r283", "r289" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Stock-based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r49", "r84", "r85", "r86", "r87", "r88", "r92", "r93", "r97", "r98", "r99", "r103", "r104", "r318", "r319", "r373", "r386" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic and diluted net loss per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r100", "r101", "r102", "r105" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Loss Per Common Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/LossPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Recognized weighted-average period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r282" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized compensation related to unvested options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r44", "r45", "r46", "r79", "r80", "r81", "r83", "r89", "r91", "r107", "r146", "r219", "r226", "r284", "r285", "r286", "r300", "r301", "r317", "r323", "r324", "r325", "r326", "r327", "r328", "r336", "r387", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r12", "r157" ], "calculation": { "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r151", "r154", "r157", "r159", "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails", "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r157", "r353" ], "calculation": { "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Total Intangible Assets" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails", "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r151", "r156" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails", "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r157", "r352" ], "calculation": { "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets:" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-lived intangible assets, amortization method" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails", "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r152" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Acquired intangible assets" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r65", "r206", "r207" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://usaqcorp.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows", "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r54" ], "calculation": { "http://usaqcorp.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r52", "r76", "r123", "r125", "r128", "r131", "r133", "r145", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r321" ], "calculation": { "http://usaqcorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedIntangibleAssetDescription": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "A description of the finite or indefinite-lived intangible asset (excluding goodwill) that is impaired.", "label": "Impaired intangible asset" } } }, "localname": "ImpairedIntangibleAssetDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r165", "r166" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r77", "r293", "r294", "r297", "r302", "r303", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r43", "r291", "r292", "r294", "r295", "r296", "r299" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r69" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r64" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase/(decrease) in accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r64" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Increase in accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r64" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase in accrued interest" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r64" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "(Increase)/decrease in inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "auth_ref": [ "r64" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current liabilities classified as other.", "label": "Decrease in other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r64" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Increase in prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r153", "r158" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r153", "r158" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r150", "r155" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r47", "r122", "r330", "r333", "r374" ], "calculation": { "http://usaqcorp.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r59", "r61", "r69" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r27", "r347" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r7", "r26", "r72", "r106", "r147", "r148", "r149", "r349" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r65" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of Stock and Warrants for Services or Claims", "verboseLabel": "Shares issued for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r31", "r76", "r127", "r145", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r312", "r314", "r315", "r321", "r345", "r346" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r25", "r76", "r145", "r321", "r347", "r370", "r383" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r33", "r76", "r145", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r312", "r314", "r315", "r321", "r345", "r346", "r347" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r8", "r9", "r10", "r16", "r17", "r76", "r145", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r312", "r314", "r315", "r321", "r345", "r346" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r16", "r369", "r376" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Loan payable" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermLoansPayable": { "auth_ref": [ "r36" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Loans payable, non-current portion" } } }, "localname": "LongTermLoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r36", "r171" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r111", "r119" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "The Company" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Company" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r60" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r60" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r60", "r63", "r66" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r41", "r42", "r46", "r48", "r66", "r76", "r82", "r84", "r85", "r86", "r87", "r90", "r91", "r96", "r123", "r125", "r128", "r131", "r133", "r145", "r172", "r173", "r174", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r319", "r321", "r372", "r385" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://usaqcorp.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows", "http://usaqcorp.com/role/StatementsOfOperations", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://usaqcorp.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Operating Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r123", "r125", "r128", "r131", "r133" ], "calculation": { "http://usaqcorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Net operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r298" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OptionMember": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received).", "label": "Options Held [Member]" } } }, "localname": "OptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r32", "r347" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails", "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForLoans": { "auth_ref": [ "r62" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments for and related to principal collection on loans related to operating activities.", "label": "Payments for loan" } } }, "localname": "PaymentsForLoans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForSoftware": { "auth_ref": [ "r55" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "Payments for Software", "negatedLabel": "Capitalized software" } } }, "localname": "PaymentsForSoftware", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r19", "r212" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value", "verboseLabel": "Preferred stock stated value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheetsParenthetical", "http://usaqcorp.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r19", "r212" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "Preferred Stock" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/PreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r19", "r347" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r19", "r220" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Preferred stock voting rights description" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r28" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r57" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds of loan borrowings" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r140", "r142", "r143", "r144" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r242", "r339", "r340" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r242", "r339", "r342", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r337", "r338", "r340", "r343", "r344" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r58" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-Term Debt", "negatedLabel": "Repayments of loan borrowings" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research and Development [Abstract]" } } }, "localname": "ResearchAndDevelopmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r290", "r350", "r397" ], "calculation": { "http://usaqcorp.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development", "verboseLabel": "Research and development expense" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative", "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.", "label": "Capitalized Software and Intangible Assets" } } }, "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r162", "r163", "r397" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Capitalized Software Development Costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r22", "r226", "r347", "r382", "r390", "r391" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r79", "r80", "r81", "r83", "r89", "r91", "r146", "r284", "r285", "r286", "r300", "r301", "r317", "r387", "r389" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r120", "r121", "r124", "r129", "r130", "r134", "r135", "r136", "r237", "r238", "r351" ], "calculation": { "http://usaqcorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r73", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r239" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationOfEarningPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Anti-dilutive Securities Excluded From Calculation of Earning Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/LossPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r240", "r241" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r278", "r288" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule of Stock-based Compensation Expenses" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r151", "r156", "r352" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails", "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r151", "r156" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/CapitalizedSoftwareAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r158", "r161" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r243", "r245", "r248", "r249", "r250", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r269", "r270", "r273", "r274", "r275", "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails", "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Fair Value of Option Grant of Weighted-average Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r18", "r19", "r20", "r75", "r108", "r109", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r227", "r246" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Warrants Outstanding and Exercisable" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://usaqcorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfStock-basedCompensationExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r18", "r19", "r219" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/BalanceSheetsParenthetical", "http://usaqcorp.com/role/PreferredStockDetailsNarrative", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r64" ], "calculation": { "http://usaqcorp.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation", "verboseLabel": "Share-Based Payment Arrangement, Noncash Expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows", "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Options vesting term" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.", "label": "Expiration Date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails", "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Expected dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfFairValueOfOptionGrantOfWeighted-averageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility of the underlying stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfFairValueOfOptionGrantOfWeighted-averageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfFairValueOfOptionGrantOfWeighted-averageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails", "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "verboseLabel": "Number Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Number Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Number Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Schedule of Options Outstanding and Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r248", "r249", "r250", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r269", "r270", "r273", "r274", "r275", "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfOptionsOutstandingAndExercisableDetails", "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted-average exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r251", "r271", "r272", "r273", "r274", "r277", "r287", "r289" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "verboseLabel": "Stock-based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Options expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected life of the options" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfFairValueOfOptionGrantOfWeighted-averageAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Unrecognized compensation related to unvested options, shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Weighted-average fair value for options granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r14", "r347", "r368", "r380" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Loans payable, current portion" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r18", "r19", "r20", "r75", "r76", "r93", "r94", "r95", "r97", "r99", "r108", "r109", "r110", "r145", "r172", "r176", "r177", "r178", "r181", "r182", "r212", "r213", "r216", "r217", "r219", "r321", "r416" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/BalanceSheetsParenthetical", "http://usaqcorp.com/role/PreferredStockDetailsNarrative", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r39", "r44", "r45", "r46", "r79", "r80", "r81", "r83", "r89", "r91", "r107", "r146", "r219", "r226", "r284", "r285", "r286", "r300", "r301", "r317", "r323", "r324", "r325", "r326", "r327", "r328", "r336", "r387", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/BalanceSheetsParenthetical", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r79", "r80", "r81", "r107", "r351" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/BalanceSheetsParenthetical", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r38", "r197", "r219", "r220", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Conversion of notes payable, shares", "verboseLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Shares issued for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r39", "r219", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Conversion of notes payable", "verboseLabel": "Stock Issued During Period, Value, Conversion of Convertible Securities" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Shares issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r19", "r20", "r219", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/PreferredStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r19", "r20", "r219", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Cancellation of shares, shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r19", "r20", "r219", "r226" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Cancellation of shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r20", "r23", "r24", "r76", "r141", "r145", "r321", "r347" ], "calculation": { "http://usaqcorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets", "http://usaqcorp.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r329", "r348" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r329", "r348" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r329", "r348" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow activity:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfIndefinite-livedIntangibleAssetsDetails", "http://usaqcorp.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://usaqcorp.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r112", "r113", "r114", "r115", "r116", "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r92", "r99" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares outstanding (basic and diluted)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://usaqcorp.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r169": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r208": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r289": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r306": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "83", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r344": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756" }, "r399": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "730", "Topic": "985", "URI": "https://asc.fasb.org/subtopic&trid=2197926" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r401": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r402": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r403": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r404": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r405": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r406": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r407": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r408": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r409": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r410": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r411": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r412": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r413": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r414": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r415": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r416": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r417": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r418": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r419": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r420": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" } }, "version": "2.1" } ZIP 55 0001493152-22-013812-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-013812-xbrl.zip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� 4<\!IN[ @6LBKGJ$A#+J:0=:GY5=%D"B?H%H'L6(U87@?[."D&\E'G? M+U]%Y3VW
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�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end